Davies NP; Brew BJ, 2011, 'The pathobiology of HIV related neuropathies', in Gendelman HE (ed.), Cognitive Neurology: a clinical textbook, edn. 3rd edition, Oxford University Press, Oxford

Gisslen M; Hagberg L; Cinque P; Brew B; Price RW, 2009, 'Cerebrospinal Fluid Markers in the Management of Central Nervous System HIV Infection and the AIDS Dementia Complex', in Goodkin K; Shapshak P; Verma A (ed.), SPECTRUM OF NEURO-AIDS DISORDERS: PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT, AMER SOC MICROBIOLOGY, pp. 173 - 179, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279006800014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ, 2009, 'Global Issues in Neuro-AIDS and Their Evolution over the Future of the HAART Era', in Goodkin K; Shapshak P; Verma A (ed.), SPECTRUM OF NEURO-AIDS DISORDERS: PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT, AMER SOC MICROBIOLOGY, pp. 507 - 523, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279006800037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Paul R; Sacktor N; Cysique LA; Brew BJ; Valcour V, 2009, 'Impact of clade diversity on neuropsychological outcomes', in Paul R; Sacktor N; Valcour V; Tashima K (ed.), HIV and the Brain: New Challenges in the Modern Era, edn. 1st, Humana Press Inc, Totowa, pp. 319 - 330

Cysique LA; Brew BJ, 2009, 'The assessment of HIV-associated neurocognitive disorders: New challenges in the HAART era', in Paul R; Sacktor N; Valcour V; Tashima K (ed.), HIV and the Brain: New Challenges in the Modern Era, edn. 1st, Humana Press Inc, Totowa, pp. 109 - 132

Loy CT; Tomlinson S; Brew BJ, 2005, 'HIV-related neurological disease in the era of HAART', in Emerging Neurological Infections, pp. 427 - 452

Brew BJ, 2002, 'Neurological manaifestations of HIV Infection', in Crowe S; Hoy J; Mills J (ed.), Management of the HIV-infected Patient (2nd Ed), edn. Original, Martin Dunitz, London, UK, pp. 161 - 182

Brew BJ, 1996, 'Neurological manifestations of HIV infection', in Management of the HIV-infected Patient, edn. Original, Cambridge University Press, Cambridge, pp. 109 - 124

Brew BJ, 1996, 'Neurologic manifestations of HIV infection', in Management of the HIV-infected Patient, edn. Original, Cambridge University Press, Cambridge, pp. 109 - 124

Sutherland EJ; Brew BJ, 2018, 'Human Immunodeficiency Virus and the Nervous System', Neurologic Clinics, vol. 36, pp. 751 - 765, http://dx.doi.org/10.1016/j.ncl.2018.07.002

Wilson MR; O'Donovan BD; Gelfand JM; Sample HA; Chow FC; Betjemann JP; Shah MP; Richie MB; Gorman MP; Hajj-Ali RA, 2018, 'Chronic meningitis investigated via metagenomic next-generation sequencing', JAMA Neurology, vol. 75, pp. 947 - 955, http://dx.doi.org/10.1001/jamaneurol.2018.0463

Wright EJ; Grund B; Robertson KR; Cysique L; Brew BJ; Collins GL; Poehlman-Roediger M; Vjecha MJ; Penalva De Oliveira AC; Standridge B, 2018, 'No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4 ⁺ T-cell counts', AIDS, vol. 32, pp. 985 - 997, http://dx.doi.org/10.1097/QAD.0000000000001778

Brew BJ; Garber JY, 2018, 'Neurologic sequelae of primary HIV infection', Handbook of Clinical Neurology, vol. 152, pp. 65 - 74, http://dx.doi.org/10.1016/B978-0-444-63849-6.00006-2

Smail RC; Brew BJ, 2018, 'HIV-associated neurocognitive disorder', Handbook of Clinical Neurology, vol. 152, pp. 75 - 97, http://dx.doi.org/10.1016/B978-0-444-63849-6.00007-4

Brew BJ, 2018, 'Introduction to HIV infection and HIV neurology', Handbook of Clinical Neurology, vol. 152, pp. 1 - 2, http://dx.doi.org/10.1016/B978-0-444-63849-6.00001-3

Zhai S; Brew BJ, 2018, 'Progressive multifocal leukoencephalopathy', Handbook of Clinical Neurology, vol. 152, pp. 123 - 137, http://dx.doi.org/10.1016/B978-0-444-63849-6.00010-4

Warhurst S; Rofe CJ; Brew BJ; Bateson D; McGeechan K; Merki-Feld GS; Garrick R; Tomlinson SE, 2018, 'Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis', Cephalalgia, vol. 38, pp. 754 - 764, http://dx.doi.org/10.1177/0333102417710636

Anderson AM; Croteau D; Ellis RJ; Rosario D; Potter M; Guillemin GJ; Brew BJ; Woods SP; Letendre SL, 2018, 'HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau', Journal of Neuroimmunology, vol. 319, pp. 13 - 18, http://dx.doi.org/10.1016/j.jneuroim.2018.03.007

Cysique LA; Jugé L; Gates T; Tobia M; Moffat K; Brew BJ; Rae C, 2018, 'Covertly active and progressing neurochemical abnormalities in suppressed HIV infection', Neurology: Neuroimmunology and NeuroInflammation, vol. 5, http://dx.doi.org/10.1212/NXI.0000000000000430

Radd-Vagenas S; Duffy SL; Naismith SL; Brew BJ; Flood VM; Fiatarone Singh MA, 2018, 'Effect of the Mediterranean diet on cognition and brain morphology and function: A systematic review of randomized controlled trials', American Journal of Clinical Nutrition, vol. 107, pp. 389 - 404, http://dx.doi.org/10.1093/ajcn/nqx070

Bundell C; Brunt SJ; Cysique LA; Brusch A; Brew BJ; Price P, 2018, 'The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy', Pathology, vol. 50, pp. 313 - 316, http://dx.doi.org/10.1016/j.pathol.2017.10.017

Haggstrom L; Brew B; Sutton I; Tisch S, 2018, 'Vestibular symptoms as the presenting feature of progressive supranuclear palsy', Journal of Clinical Neuroscience, vol. 50, pp. 74 - 76, http://dx.doi.org/10.1016/j.jocn.2018.01.021

Chaganti JR; Heinecke A; Gates TM; Moffat KJ; Brew BJ, 2017, 'Functional connectivity in virally suppressed patients with HIV-associated neurocognitive disorder: A resting-state analysis', American Journal of Neuroradiology, vol. 38, pp. 1623 - 1629, http://dx.doi.org/10.3174/ajnr.A5246

Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration (Journal of NeuroVirology, (2017), 23, 4, (539-547), 10.', Journal of NeuroVirology, vol. 23, pp. 548 - 549, http://dx.doi.org/10.1007/s13365-017-0542-z

Brew BJ; Cysique L, 2017, 'Does HIV prematurely age the brain?', The Lancet HIV, vol. 4, pp. e380 - e381, http://dx.doi.org/10.1016/S2352-3018(17)30108-X

Bukhari W; Prain KM; Waters P; Woodhall M; O'Gorman CM; Clarke L; Silvestrini RA; Bundell CS; Abernethy D; Bhuta S, 2017, 'Incidence and prevalence of NMOSD in Australia and New Zealand', Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 632 - 638, http://dx.doi.org/10.1136/jnnp-2016-314839

Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ, 2017, 'Bcl11b-A critical neurodevelopmental transcription factor-roles in health and disease', Frontiers in Cellular Neuroscience, vol. 11, http://dx.doi.org/10.3389/fncel.2017.00089

Brew B; Carroll A, 2017, 'HIV-associated neurocognitive disorders: Recent advances in pathogenesis, biomarkers, and treatment', F1000Research, vol. 6, http://dx.doi.org/10.12688/f1000research.10651.1

Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration', Journal of NeuroVirology, vol. 23, pp. 539 - 547, http://dx.doi.org/10.1007/s13365-017-0524-1

Gott C; Gates T; Dermody N; Brew BJ; Cysique LA, 2017, 'Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0171887

Kamminga J; Lal L; Wright EJ; Bloch M; Brew BJ; Cysique LA, 2017, 'Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use', Current HIV/AIDS Reports, vol. 14, pp. 83 - 92, http://dx.doi.org/10.1007/s11904-017-0349-9

Gott C; Gates T; Dermody N; Brew BJ; Cysique LA, 2017, 'Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity.', PLoS One, vol. 12, pp. e0171887, http://dx.doi.org/10.1371/journal.pone.0171887

Lim CK; Bilgin A; Lovejoy DB; Tan V; Bustamante S; Taylor BV; Bessede A; Brew BJ; Guillemin GJ, 2017, 'Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/srep41473

Ellero J; Lubomski M; Brew B, 2017, 'Interventions for Neurocognitive Dysfunction', Current HIV/AIDS Reports, vol. 14, pp. 8 - 16, http://dx.doi.org/10.1007/s11904-017-0346-z

Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA, 2017, 'Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure', Journal of Clinical and Experimental Neuropsychology, vol. 39, pp. 753 - 767, http://dx.doi.org/10.1080/13803395.2016.1263282

Lee JM; Tan V; Lovejoy D; Braidy N; Rowe DB; Brew BJ; Guillemin GJ, 2017, 'Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis', Neuropharmacology, vol. 112, pp. 346 - 364, http://dx.doi.org/10.1016/j.neuropharm.2016.05.011

Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ, 2017, 'Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases', Neuropharmacology, vol. 112, pp. 373 - 388, http://dx.doi.org/10.1016/j.neuropharm.2016.03.024

Anesten B; Yilmaz A; Hagberg L; Zetterberg H; Nilsson S; Brew BJ; Fuchs D; Price RW; Gisslén M, 2016, 'Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV', Neurology: Neuroimmunology and NeuroInflammation, vol. 3, http://dx.doi.org/10.1212/NXI.0000000000000300

Tobia M; Jones S; Lovelace M; Rae C; Cysique L; Brew B, 2016, 'Reduced cellular energy as a potential marker of HIV brain latency related neuropathogenesis: a pilot study', JOURNAL OF NEUROVIROLOGY, vol. 22, pp. S76 - S77, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394093700158&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA, 2016, 'A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review', Clinical Infectious Diseases, vol. 63, pp. 687 - 693, http://dx.doi.org/10.1093/cid/ciw399

Nadel J; O'Dwyer E; Emmanuel S; Huang J; Cheruvu S; Sammel N; Brew B; Otton J; Holloway CJ, 2016, 'High-risk coronary plaque, invasive coronary procedures, and cardiac events among HIV-positive individuals and matched controls', Journal of Cardiovascular Computed Tomography, vol. 10, pp. 391 - 397, http://dx.doi.org/10.1016/j.jcct.2016.07.018

Lovelace MD; Varney B; Sundaram G; Franco NF; Ng ML; Pai S; Lim CK; Guillemin GJ; Brew BJ, 2016, 'Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis', Frontiers in Immunology, vol. 7, http://dx.doi.org/10.3389/fimmu.2016.00246

Brew BJ, 2016, 'Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment?', AIDS, vol. 30, pp. 2379 - 2380, http://dx.doi.org/10.1097/QAD.0000000000001225

Braidy N; Rossez H; Lim CK; Jugder BE; Brew BJ; Guillemin GJ, 2016, 'Characterization of the Kynurenine Pathway in CD8⁺ Human Primary Monocyte-Derived Dendritic Cells', Neurotoxicity Research, vol. 30, pp. 620 - 632, http://dx.doi.org/10.1007/s12640-016-9657-x

Walker S; Brew B, 2016, 'Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis', Journal of Clinical Neuroscience, vol. 31, pp. 217 - 218, http://dx.doi.org/10.1016/j.jocn.2016.03.001

Brunt SJ; Cysique LA; Lee S; Burrows S; Brew BJ; Price P, 2016, 'Short communication: Do cytomegalovirus antibody levels associate with age-related syndromes in HIV patients stable on antiretroviral therapy?', AIDS Research and Human Retroviruses, vol. 32, pp. 567 - 572, http://dx.doi.org/10.1089/aid.2015.0328

Gray LR; Brew BJ; Churchill MJ, 2016, 'Strategies to target HIV-1 in the central nervous system', Current Opinion in HIV and AIDS, vol. 11, pp. 371 - 375, http://dx.doi.org/10.1097/COH.0000000000000278

Gates TM; Cysique LA; Siefried KJ; Chaganti J; Moffat KJ; Brew BJ, 2016, 'Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder', AIDS, vol. 30, pp. 591 - 600, http://dx.doi.org/10.1097/QAD.0000000000000951

Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2016, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, vol. 22, pp. 56 - 65, http://dx.doi.org/10.1007/s13365-015-0368-5

Crossley KM; Agnihotri S; Chaganti J; Rodriguez ML; McNally LP; Venna N; Turbett SE; Gutman M; Morey A; Koralnik IJ, 2016, 'Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals', Journal of NeuroVirology, vol. 22, pp. 541 - 545, http://dx.doi.org/10.1007/s13365-015-0419-y

Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ, 2016, 'Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?', Neurotoxicity Research, vol. 29, pp. 201 - 207, http://dx.doi.org/10.1007/s12640-015-9573-5

Gray LR; Cowley D; Welsh C; Lu HK; Brew BJ; Lewin SR; Wesselingh SL; Gorry PR; Churchill MJ, 2016, 'CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies', Molecular Psychiatry, vol. 21, pp. 574 - 584, http://dx.doi.org/10.1038/mp.2015.111

Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD; Agan BK; Alston-Smith B, 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial', HIV Medicine, vol. 16, pp. 1 - 9, http://dx.doi.org/10.1111/hiv.12227

Watts J; Brew B; Tisch S, 2015, 'Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria', Journal of Clinical Neuroscience, vol. 22, pp. 1979 - 1981, http://dx.doi.org/10.1016/j.jocn.2015.05.032

Inder KJ; Hussain R; Allen J; Brew B; Lewin TJ; Attia J; Kelly BJ, 2015, 'Factors associated with personal hopefulness in older rural and urban residents of New South Wales', Advances in Mental Health, vol. 13, pp. 43 - 57, http://dx.doi.org/10.1080/18374905.2015.1039186

Brew BJ; Robertson K; Wright EJ; Churchill M; Crowe SM; Cysique LA; Deeks S; Garcia JV; Gelman B; Gray LR, 2015, 'HIV eradication symposium: will the brain be left behind?', Journal of NeuroVirology, vol. 21, pp. 322 - 334, http://dx.doi.org/10.1007/s13365-015-0322-6

Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2015, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults', Journal of NeuroVirology, http://dx.doi.org/10.1007/s13365-015-0368-5

Jones SP; Franco NF; Varney B; Sundaram G; Brown DA; De Bie J; Lim CK; Guillemin GJ; Brew BJ, 2015, 'Expression of the kynurenine pathway in human peripheral blood mononuclear cells: Implications for inflammatory and neurodegenerative disease', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0131389

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA, 2015, 'A new era in the treatment of multiple sclerosis', Medical Journal of Australia, vol. 203, pp. 139 - 141, http://dx.doi.org/10.5694/mja14.01218

Britton PN; Eastwood K; Brew BJ; Nagree Y; Jones CA, 2015, 'Consensus guidelines for the investigation and management of encephalitis', Medical Journal of Australia, vol. 202, pp. 576 - 577, http://dx.doi.org/10.5694/mja14.01042

Fois AF; Brew BJ, 2015, 'The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication', Current HIV/AIDS Reports, vol. 12, pp. 299 - 303, http://dx.doi.org/10.1007/s11904-015-0257-9

Cysique LA; Hey-Cunningham WJ; Dermody N; Chan P; Brew BJ; Koelsch KK, 2015, 'Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0120488

Britton PN; Eastwood K; Paterson B; Durrheim DN; Dale RC; Cheng AC; Kenedi C; Brew BJ; Burrow J; Nagree Y, 2015, 'Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand', Internal Medicine Journal, vol. 45, pp. 563 - 576, http://dx.doi.org/10.1111/imj.12749

Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CSN; Davies NNWS; Price P; Brew BJ, 2015, 'APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - A cross-sectional observational study', BMC Neurology, vol. 15, http://dx.doi.org/10.1186/s12883-015-0298-0

Wright EJ; Grund B; Cysique LA; Robertson KR; Brew BJ; Collins G; Shlay JC; Winston A; Read TRH; Price RW, 2015, 'Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.', HIV Med, vol. 16 Suppl 1, pp. 97 - 108, http://dx.doi.org/10.1111/hiv.12238

Braidy N; Brew BJ; Inestrosa NC; Chung R; Sachdev P; Guillemin GJ, 2014, 'Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons', Metabolic brain disease, vol. 29, pp. 873 - 883, http://dx.doi.org/10.1007/s11011-014-9557-9

Chan P; Brew BJ, 2014, 'HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment', Current HIV/AIDS reports, vol. 11, pp. 317 - 324, http://dx.doi.org/10.1007/s11904-014-0221-0

Sundaram G; Brew BJ; Jones SP; Adams S; Lim CK; Guillemin GJ, 2014, 'Quinolinic acid toxicity on oligodendroglial cells: Relevance for multiple sclerosis and therapeutic strategies', Journal of Neuroinflammation, vol. 11, http://dx.doi.org/10.1186/s12974-014-0204-5

Power C; Brew BJ, 2014, 'HIV-1 infection and the nervous system-a shifting target.', Current Opinion in HIV and AIDS, vol. 9, pp. 515 - 516, http://dx.doi.org/10.1097/COH.0000000000000113

Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ, 2014, 'Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after d', Journal of Clinical Neuroscience, http://dx.doi.org/10.1016/j.jocn.2014.08.016

Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ, 2014, 'Involvement of the kynurenine pathway in human glioma pathophysiology.', PLoS One, vol. 9, pp. e112945, http://dx.doi.org/10.1371/journal.pone.0112945

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies', Journal of Clinical Neuroscience, vol. 21, pp. 1835 - 1846, http://dx.doi.org/10.1016/j.jocn.2014.01.016

Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ, 2014, 'HIV-associated neurocognitive disorder in Australia: A case of a high-functioning and optimally treated cohort and implications for international neuroHIV research', Journal of NeuroVirology, vol. 20, pp. 258 - 268, http://dx.doi.org/10.1007/s13365-014-0242-x

Chan P; Brew BJ, 2014, 'HIV Associated Neurocognitive Disorders in the Modern Antiviral Treatment Era: Prevalence, Characteristics, Biomarkers, and Effects of Treatment', Current HIV/AIDS Reports, http://dx.doi.org/10.1007/s11904-014-0221-0

Broadley SA; Barnett MH; Reddel SW; Spies J; Pollard JD; Boggild M; Brew BJ; Butzkueven H; Marriott M; Heard R, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy', Journal of Clinical Neuroscience, http://dx.doi.org/10.1016/j.jocn.2014.01.018

Broadley SA; Barnett MH; Reddel SW; Spies J; Pollard JD; Boggild M; Brew BJ; Butzkueven H; Marriott M; Heard R, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations', Journal of Clinical Neuroscience, http://dx.doi.org/10.1016/j.jocn.2014.01.017

Brew BJ; Chan P, 2014, 'Update on HIV dementia and HIV-associated neurocognitive disorders', Current Neurology and Neuroscience Reports, vol. 14, http://dx.doi.org/10.1007/s11910-014-0468-2

Cysique LA; Brew BJ, 2014, 'The effects of HIV and aging on brain functions: Proposing a research framework and update on last 3 years' findings', Current Opinion in HIV and AIDS, http://dx.doi.org/10.1097/COH.0000000000000078

Dwyer R; Wenhui L; Cysique L; Brew BJ; Lal L; Bain P; Wesselingh S; Wright EJ, 2014, 'Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China', Journal of Affective Disorders, vol. 162, pp. 89 - 95, http://dx.doi.org/10.1016/j.jad.2014.03.038

Lu GM; Brew BJ; Siefried KJ; Draper B; Cysique LA, 2014, 'Is the HIV dementia scale a reliable tool for assessing HIV-relatedneurocognitive decline?', Journal of AIDS and Clinical Research, vol. 5, http://dx.doi.org/10.4172/2155-6113.1000269

Antinori A; Arendt G; Grant I; Letendre S; Muñoz-Moreno JA; Eggers C; Brew B; Brouillette MJ; Bernal-Cano F; Carvalhal A, 2013, 'Assessment, diagnosisand treatment of Human Immunodeficiency Virus (HIV)-associated neurocognitive disorders (HAND): A consensus report of the mind exchange program', Clinical Infectious Diseases, vol. 56, pp. 1004 - 1017, http://dx.doi.org/10.1093/cid/cis975

Jones SP; Guillemin GJ; Brew BJ, 2013, 'The kynurenine pathway in stem cell biology', International Journal of Tryptophan Research, vol. 6, pp. 57 - 66, http://dx.doi.org/10.4137/IJTR.S12626

LeWitt PA; Boroojerdi B; Surmann E; Poewe W; SP716 Study Group; SP715 Study Group, 2013, 'Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.', J Neural Transm (Vienna), vol. 120, pp. 1069 - 1081, http://dx.doi.org/10.1007/s00702-012-0925-5

Brown S; Simpson DM; Moyle G; Brew BJ; Schifitto G; Larbalestier N; Orkin C; Fisher M; Vanhove GF; Tobias JK, 2013, 'NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: Integrated analysis of two phase III, randomized, controlled trials', AIDS Research and Therapy, vol. 10, http://dx.doi.org/10.1186/1742-6405-10-5

Brew BJ; Gray L; Lewin S; Churchill M, 2013, 'Is specific HIV eradication from the brain possible or needed?', Expert Opinion on Biological Therapy, vol. 13, pp. 403 - 409, http://dx.doi.org/10.1517/14712598.2013.748029

Brew BJ; McLean CA; Major EO, 2013, 'Progressive multifocal leukoencephalopathy caused by BK virus?', Medical Journal of Australia, vol. 198, pp. 179 - 180, http://dx.doi.org/10.5694/mja12.11798

Mora-Peris B; MacKie NE; Suan D; Cooper DA; Brew BJ; Winston A, 2013, 'Raltegravir resistance in the cerebrospinal fluid', Infection, vol. 41, pp. 731 - 734, http://dx.doi.org/10.1007/s15010-013-0409-z

Crossley KM; Brew BJ, 2013, 'Neurological complications in controlled HIV infection', Current Infectious Disease Reports, vol. 15, pp. 564 - 568, http://dx.doi.org/10.1007/s11908-013-0375-8

Kamminga J; Cysique LA; Lu G; Batchelor J; Brew BJ, 2013, 'Validity of cognitive screens for HIV-associated neurocognitive disorder: A systematic review and an informed screen selection guide', Current HIV/AIDS Reports, vol. 10, pp. 342 - 355, http://dx.doi.org/10.1007/s11904-013-0176-6

Braidy N; Lim CK; Grant R; Brew BJ; Guillemin GJ, 2013, 'Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis', Brain Research, vol. 1537, pp. 267 - 272, http://dx.doi.org/10.1016/j.brainres.2013.08.025

Braidy N; Lim CK; Guillemin GJ; Grant R; Brew BJ, 2013, 'Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis', Brain Research, http://dx.doi.org/10.1016/j.brainres.2013.08.025

Grund B; Wright EJ; Brew BJ; Price RW; Roediger MP; Bain MP; Hoy JF; Shlay JC; Vjecha MJ; Robertson KR, 2013, 'Improved neurocognitive test performance in both arms of the SMART study: Impact of practice effect', Journal of NeuroVirology, vol. 19, pp. 383 - 392, http://dx.doi.org/10.1007/s13365-013-0190-x

Clifford DB; Nath A; Cinque P; Brew BJ; Zivadinov R; Gorelik L; Zhao Z; Duda P, 2013, 'A study of mefloquine treatment for progressive multifocal leukoencephalopathy: Results and exploration of predictors of PML outcomes', Journal of NeuroVirology, vol. 19, pp. 351 - 358, http://dx.doi.org/10.1007/s13365-013-0173-y

Sasson SC; Oon A; Chagantri J; Brew BJ; Carr A, 2013, 'Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: A case report', BMC Infectious Diseases, vol. 13, http://dx.doi.org/10.1186/1471-2334-13-396

Wu W; Nicolazzo JA; Wen L; Chung R; Stankovic R; Bao SS; Lim CK; Brew BJ; Cullen KM; Guillemin GJ, 2013, 'Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0059749

Joseph J; Achim CL; Boivin MJ; Brew BJ; Clifford DB; Colosi DA; Ellis RJ; Heaton RK; Gallo-Diop A; Grant I, 2013, 'Global NeuroAIDS roundtable', Journal of NeuroVirology, vol. 19, pp. 1 - 9, http://dx.doi.org/10.1007/s13365-012-0143-9

Gray LR; Tachedjian G; Ellett AM; Roche MJ; Cheng WJ; Guillemin GJ; Brew BJ; Turville SG; Wesselingh SL; Gorry PR, 2013, 'The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0062196

Peluso MJ; Meyerhoff DJ; Price RW; Peterson J; Lee E; Young AC; Walter R; Fuchs D; Brew BJ; Cinque P, 2013, 'Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection', Journal of Infectious Diseases, vol. 207, pp. 1703 - 1712, http://dx.doi.org/10.1093/infdis/jit088

Gray L; Tachedjian G; Ellett A; Roche M; Brew B; Turville S; Wesselingh S; Gorry P; Churchill M, 2012, 'Reduced Effectiveness of the NRTIs d4T and AZT in Astrocytes: Implications for Neuro-cART', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 42 - 43, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Peluso M; Price R; Peterson J; Lee E; Fuchs D; Brew B; Cinque P; Hagberg L; Zetterberg H; Gisslen M, 2012, 'Primary HIV-1 infection is characterized by elevation of cerebrospinal fluid biomarkers indicating early neuronal damage', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 83 - 84, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Chew C; Cysique L; Brew B; Price P, 2012, 'Relationships between genetic markers of neuroinflammation, neurodegeneration and neurocognitive impairment in controlled HIV infection', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 23 - 24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Cysique L; Brew B, 2012, 'Characteristics of neurocognitive decline in virally-suppressed middle-aged HIV plus individuals', JOURNAL OF NEUROVIROLOGY, vol. 18, pp. 26 - 26, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304487800054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Mothobi NZ; Brew BJ, 2012, 'Neurocognitive dysfunction in the highly active antiretroviral therapy era', Current Opinion in Infectious Diseases, vol. 25, pp. 4 - 9, http://dx.doi.org/10.1097/QCO.0b013e32834ef586

Clifford DB; Simpson DM; Brown S; Moyle G; Brew BJ; Conway B; Tobias JK; Vanhove GF, 2012, 'A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful hiv-associated distal sensory polyneuropathy', Journal of Acquired Immune Deficiency Syndromes, vol. 59, pp. 126 - 133, http://dx.doi.org/10.1097/QAI.0b013e31823e31f7

Blair NF; Brew BJ; Halpern JP, 2012, 'Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance', Neurology, vol. 78, pp. 507 - 508, http://dx.doi.org/10.1212/WNL.0b013e318246d6d8

Brew BJ; Thompson J, 2012, 'Epilepsy: Issues with antiepileptic drug use in HIV-infected patients', Nature Reviews Neurology, vol. 8, pp. 187 - 188, http://dx.doi.org/10.1038/nrneurol.2012.36

Adams S; Braidy N; Bessede A; Brew BJ; Grant R; Teo C; Guillemin GJ, 2012, 'Correction: The kynurenine pathway in brain tumor pathogenesis (Cancer Research (2012) 72, (5649-5657))', Cancer Research, vol. 72, pp. 6524, http://dx.doi.org/10.1158/0008-5472.CAN-12-4230

Kandanearatchi A; Brew BJ, 2012, 'The kynurenine pathway and quinolinic acid: Pivotal roles in HIV associated neurocognitive disorders', FEBS Journal, vol. 279, pp. 1366 - 1374, http://dx.doi.org/10.1111/j.1742-4658.2012.08500.x

Lim CK; Yap MMC; Kent SJ; Gras G; Samah B; Batten JC; De Rose R; Heng B; Brew BJ; Guillemin GJ, 2012, 'Characterization of the Kynurenine pathway and quinolinic acid production in macaque macrophages', International Journal of Tryptophan Research, vol. 6, pp. 7 - 19, http://dx.doi.org/10.4137/IJTR.S11789

Cruse B; Cysique LA; Markus R; Brew BJ, 2012, 'Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy', Journal of NeuroVirology, vol. 18, pp. 264 - 276, http://dx.doi.org/10.1007/s13365-012-0092-3

Lane TA; Moore DM; Batchelor J; Brew BJ; Cysique LA, 2012, 'Facial emotional processing in HIV infection: Relation to neurocognitive and neuropsychiatric status', Neuropsychology, vol. 26, pp. 713 - 722, http://dx.doi.org/10.1037/a0029964

Adams S; Braidy N; Bessesde A; Brew BJ; Grant R; Teo C; Guillemin GJ, 2012, 'The kynurenine pathway in brain tumor pathogenesis', Cancer Research, vol. 72, pp. 5649 - 5657, http://dx.doi.org/10.1158/0008-5472.CAN-12-0549

Wright E; Grund B; Robertson K; Brew B; Price R, 2011, 'CARDIOVASCULAR RISK FACTORS ASSOCIATED WITH LOWER BASELINE COGNITIVE PERFORMANCE IN HIV-POSITIVE PERSONS Reply', NEUROLOGY, vol. 77, pp. 407 - 407, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293123300026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Wright E; Grund B; Robertson K; Brew B; Price R, 2011, 'Reply from the authors', Neurology, vol. 77, pp. 407, http://dx.doi.org/10.1212/WNL.0b013e3182246fb2

Croitoru-Lamoury J; Lamoury FMJ; Caristo M; Suzuki K; Walker D; Takikawa O; Taylor R; Brew BJ, 2011, 'Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO)', PLoS ONE, vol. 6, http://dx.doi.org/10.1371/journal.pone.0014698

Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM, 2011, 'Differential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected Individuals', PLoS ONE, vol. 6, http://dx.doi.org/10.1371/journal.pone.0019968

Maruszak H; Brew BJ; Giovannoni G; Gold J, 2011, 'Could antiretroviral drugs be effective in multiple sclerosis? A case report', European Journal of Neurology, vol. 18, http://dx.doi.org/10.1111/j.1468-1331.2011.03430.x

Ng K; Kumar K; Brew B; Burke D, 2011, 'Axonal excitability in viral polyneuropathy and nucleoside neuropathy in HIV patients', Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, pp. 978 - 980, http://dx.doi.org/10.1136/jnnp.2009.203091

Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew B; Fuchs D; Tambussi G; Cinque P; Hecht FM, 2011, 'Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden', Journal of Infectious Diseases, vol. 204, pp. 753 - 760, http://dx.doi.org/10.1093/infdis/jir387

Rahman A; Brew BJ; Guillemin GJ, 2011, 'Lead dysregulates serine/threonine protein phosphatases in human neurons', Neurochemical Research, vol. 36, pp. 195 - 204, http://dx.doi.org/10.1007/s11064-010-0300-6

Cysique LA; Waters EK; Brew BJ, 2011, 'Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research', BMC Neurology, vol. 11, http://dx.doi.org/10.1186/1471-2377-11-148

Maher AD; Cysique LA; Brew BJ; Rae CD, 2011, 'Statistical integration of ¹H NMR and MRS data from different biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection', Journal of Proteome Research, vol. 10, pp. 1737 - 1745, http://dx.doi.org/10.1021/pr1010263

Botes LP; Jin F; Bourne C; Pett S; Marriott D; Carr A; Cooper DA; Matthews G; Brew BJ; Hillman RJ, 2011, 'Participants perspectives of self-collected anal cytological swabs', Sexual Health, vol. 8, pp. 257 - 258, http://dx.doi.org/10.1071/SH10037

Hillman RJ; Pett S; Marriott D; Carr A; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, vol. 8, pp. 255 - 256, http://dx.doi.org/10.1071/SH10116

Cysique LA; Bain MP; Brew BJ; Murray JM, 2011, 'The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future', Sexual Health, vol. 8, pp. 541 - 550, http://dx.doi.org/10.1071/SH11003

McManus H; Li P; Nolan D; Bloch M; Kiertiburanakul S; Choi JY; Mulhall B; Petoumenos K; Zhou J; Law M, 2011, 'Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?', HIV Medicine, vol. 12, pp. 610 - 619, http://dx.doi.org/10.1111/j.1468-1293.2011.00938.x

Chen Y; Brew BJ; Guillemin GJ, 2011, 'Characterization of the kynurenine pathway in NSC-34 cell line: Implications for amyotrophic lateral sclerosis', Journal of Neurochemistry, vol. 118, pp. 816 - 825, http://dx.doi.org/10.1111/j.1471-4159.2010.07159.x

Maruszak A; Brew BJ; Giovannoni G; Gold J, 2011, 'Could antiretroviral drugs be effective in multiple sclerosis? A case report', European Journal of Neurology, vol. 18, pp. 110 - 111, http://dx.doi.org/10.1111/j.1468-1331.2011.03430.x/pdf

Lifson A; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Krum E; Nelson R; Pedersen C; Perez G, 2010, 'Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials', HIV Clinical Trials, vol. 11, pp. 205 - 219, http://dx.doi.org/10.1310/hct1104-205

Brew BJ, 2010, 'Neurodegeneration in the HAART era', RETROVIROLOGY, vol. 7, pp. 3 - 3, http://dx.doi.org/10.1186/1742-4690-7-S1-I7

Guillemin GJ; Rahman A; Ting K; Cullen KM; Braidy N; Chung RS; Wu W; Brew BJ, 2010, 'INVOLVEMENT OF THE KYNURENINE PATHWAY IN ALZHEIMER'S DISEASE', JOURNAL OF NEUROCHEMISTRY, vol. 115, pp. 39 - 39, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281812600096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ, 2010, 'Benefit or toxicity from neurologically targeted antiretroviral therapy?', Clinical Infectious Diseases, vol. 50, pp. 930 - 932, http://dx.doi.org/10.1086/650744

McArthur JC; Brew BJ, 2010, 'HIV-associated neurocognitive disorders: Is there a hidden epidemic?', AIDS, vol. 24, pp. 1367 - 1370, http://dx.doi.org/10.1097/QAD.0b013e3283391d56

Zhou L; Diefenbach E; Crossett B; Tran SL; Ng T; Rizos H; Rua R; Wang B; Kapur A; Gandhi K, 2010, 'First evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia', Molecular Neurodegeneration, vol. 5, http://dx.doi.org/10.1186/1750-1326-5-27

Tisch S; Brew BJ, 2010, 'HIV, HAART, and parkinson's disease: Co-incidence or pathogenetic link?', Movement Disorders, vol. 25, pp. 2257 - 2258, http://dx.doi.org/10.1002/mds.23277

Davies NWS; Guillemin G; Brew BJ, 2010, 'Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder', International Journal of Tryptophan Research, vol. 3, pp. 121 - 140

Brew BJ, 2010, 'HIV and the Acquired Immunodeficiency Syndrome: An Overview of Neurological Complications', International Neurology: A Clinical Approach, pp. 340 - 341, http://dx.doi.org/10.1002/9781444317008.ch92

Brew BJ, 2010, 'HIV-Associated Lymphoma: Neurologic Complications', International Neurology: A Clinical Approach, pp. 360 - 361, http://dx.doi.org/10.1002/9781444317008.ch98

Brew BJ, 2010, 'HIV-Associated Cerebral Opportunistic Infections', International Neurology: A Clinical Approach, pp. 356 - 359, http://dx.doi.org/10.1002/9781444317008.ch97

Cherry CL; Affandi JS; Brew BJ; Creighton J; Djauzi S; Hooker DJ; Imran D; Kamarulzaman A; Kamerman P; McArthur JC, 2010, 'Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV', Neurology, vol. 74, pp. 1538 - 1542, http://dx.doi.org/10.1212/WNL.0b013e3181dd436d

Hagberg L; Cinque P; Gisslen M; Brew BJ; Spudich S; Bestetti A; Price RW; Fuchs D, 2010, 'Cerebrospinal fluid neopterin: An informative biomarker of central nervous system immune activation in HIV-1 infection', AIDS Research and Therapy, vol. 7, http://dx.doi.org/10.1186/1742-6405-7-15

Brew BJ; Davies NWS; Cinque P; Clifford DB; Nath A, 2010, 'Progressive multifocal leukoencephalopathy and other forms of JC virus disease', Nature Reviews Neurology, vol. 6, pp. 667 - 679, http://dx.doi.org/10.1038/nrneurol.2010.164

Lim CK; Brew BJ; Sundaram G; Guillemin GJ, 2010, 'Understanding the roles of the kynurenine pathway in multiple sclerosis progression', International Journal of Tryptophan Research, vol. 3, pp. 157 - 167

Brew BJ; Cysique LA, 2010, 'Editorial: Alzheimer disease and HIV: A tangled story', Neurology, vol. 75, pp. 105 - 106, http://dx.doi.org/10.1212/WNL.0b013e3181e7b6a4

Lee MC; Ting KK; Adams S; Brew BJ; Chung R; Guillemin GJ, 2010, 'Characterisation of the expression of NMDA receptors in human astrocytes', PLoS ONE, vol. 5, http://dx.doi.org/10.1371/journal.pone.0014123

Dunbar M; Murray JM; Cysique LA; Brew BJ; Jeyakumar V, 2010, 'Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment', European Journal of Operational Research, vol. 206, pp. 470 - 478, http://dx.doi.org/10.1016/j.ejor.2010.03.017

Joseph J; Clifford D; Douglas SD; Fox H; Gendelman HE; Gonzalez-Scarano F; Grant I; Major E; McArthur J; NeuroAIDS Research Participants, 2009, 'Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008.', J Neuroimmune Pharmacol, vol. 4, pp. 283 - 297, http://dx.doi.org/10.1007/s11481-009-9159-1

Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sheffief S; Wang B; Saksena N; Purcell DFJ, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain', Journal of Virology, vol. 83, pp. 5430 - 5441, http://dx.doi.org/10.1128/JVI.02648-08

Churchill MJ; Wesselingh SL; Cowley D; Pardo CA; McArthur JC; Brew BJ; Gorry PR, 2009, 'Extensive astrocyte infection is prominent in human immunodeficiency virus - associated dementia', Annals of Neurology, vol. 66, pp. 253 - 258, http://dx.doi.org/10.1002/ana.21697

Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DFJ, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain (Journal of Virology (2009) 83,', Journal of Virology, vol. 83, pp. 7794, http://dx.doi.org/10.1128/JVI.01082-09

Tan IL; Brew BJ, 2009, 'Possible JCV granular cell neuronopathy in a patient with HIV infection', Neurology, vol. 73, pp. 1598 - 1599, http://dx.doi.org/10.1212/WNL.0b013e3181c0d6cb

Maruff P; Thomas E; Cysique L; Brew B; Collie A; Snyder P; Pietrzak RH, 2009, 'Validity of the CogState brief battery: Relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex', Archives of Clinical Neuropsychology, vol. 24, pp. 165 - 178, http://dx.doi.org/10.1093/arclin/acp010

Tisch S; Brew B, 2009, 'Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', Neurology, vol. 73, pp. 401 - 403, http://dx.doi.org/10.1212/WNL.0b013e3181b04b0d

Braidy N; Grant R; Adams S; Brew BJ; Guillemin GJ, 2009, 'Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons', Neurotoxicity Research, vol. 16, pp. 77 - 86, http://dx.doi.org/10.1007/s12640-009-9051-z

Rahman A; Ting K; Cullen KM; Braidy N; Brew BJ; Guillemin GJ, 2009, 'The excitotoxin quinolinic acid induces tau phosphorylation in human neurons', PLoS ONE, vol. 4, http://dx.doi.org/10.1371/journal.pone.0006344

Brew BJ, 2009, 'HIV, the brain, children, HAART and 'neuro-HAART': A complex mix', AIDS, vol. 23, pp. 1909 - 1910, http://dx.doi.org/10.1097/QAD.0b013e32832ec4c6

Braidy N; Grant R; Brew BJ; Adams S; Jayasena T; Guillemin GJ, 2009, 'Effects of kynurenine pathway metabolites on intracellular NAD ⁺ synthesis and cell death in human primary astrocytes and neurons', International Journal of Tryptophan Research, vol. 2, pp. 61 - 69

Ting KK; Brew BJ; Guillemin GJ, 2009, 'Effect of quinolinic acid on human astrocytes morphology and functions: Implications in Alzheimer's disease', Journal of Neuroinflammation, vol. 6, http://dx.doi.org/10.1186/1742-2094-6-36

Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW, 2009, 'Amyloid and tau cerebrospinal fluid biomarkers in HIV infection', BMC Neurology, vol. 9, http://dx.doi.org/10.1186/1471-2377-9-63

Brew BJ; Crowe SM; Landay A; Cysique LA; Guillemin G, 2009, 'Neurodegeneration and ageing in the HAART era', Journal of Neuroimmune Pharmacology, vol. 4, pp. 163 - 174, http://dx.doi.org/10.1007/s11481-008-9143-1

Cysique LA; Brew BJ, 2009, 'Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: A review', Neuropsychology Review, vol. 19, pp. 169 - 185, http://dx.doi.org/10.1007/s11065-009-9092-3

Maneglier B; Guillemin G; Clayette P; Brew B; Rogez-Kreuz C; Advenier C; Spreux-Varoquaux O, 2008, 'Involvement of tryptophan catabolism during HIV-1 infection in primary culture of human monocytes-derived macrophages', FUNDAMENTAL & CLINICAL PHARMACOLOGY, vol. 22, pp. 99 - 99, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256760500481&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Batmanian JJ; Lam M; Matthews C; Finckh A; Duffy M; Wright R; Brew BJ; Markus R, 2008, 'Tissue plasminogen activator for acute ischaemic stroke - Reply', MEDICAL JOURNAL OF AUSTRALIA, vol. 188, pp. 489 - 490, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256113000019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ; Letendre SL, 2008, 'Biomarkers of HIV related central nervous system disease', International Review of Psychiatry, vol. 20, pp. 73 - 88, http://dx.doi.org/10.1080/09540260701878082

Wright E; Brew BJ; Lal L; Ali ST; Arayawichanont A; Imran D; Kamarulzaman A; Kongsaengdao S; Kruy L; Merati TP, 2008, 'Response to Birbeck et al.', Epilepsia, vol. 49, pp. 541 - 543, http://dx.doi.org/10.1111/j.1528-1167.2007.01529_5.x

Cherry CL; Duncan AJ; MacKie KF; Wesselingh SL; Brew BJ, 2008, 'A report on the effect of commencing enfuvirtide on peripheral neuropathy', AIDS Research and Human Retroviruses, vol. 24, pp. 1027 - 1030, http://dx.doi.org/10.1089/aid.2007.0300

Pemberton LA; Stone E; Price P; Van Bockxmeer F; Brew BJ, 2008, 'The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia', HIV Medicine, vol. 9, pp. 677 - 680, http://dx.doi.org/10.1111/j.1468-1293.2008.00614.x

Wright E; Nunn M; Joseph J; Robertson K; Lal L; Brew B, 2008, 'NeuroAIDS in the Asia Pacific Region', Journal of NeuroVirology, vol. 14, pp. 465 - 473, http://dx.doi.org/10.1080/13550280802235932

Batmanian JJ; Lam M; Matthews C; Finckh A; Duffy M; Wright R; Brew BJ; Markus R, 2008, 'Reply', Medical Journal of Australia, vol. 188, pp. 489 - 490

Manéglier B; Guillemin GJ; Clayette P; Rogez-Kreuz C; Brew BJ; Dormont D; Advenier C; Therond P; Spreux-Varoquaux O, 2008, 'Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT 1A receptors', British Journal of Pharmacology, vol. 154, pp. 174 - 182, http://dx.doi.org/10.1038/bjp.2008.80

Owe-Young R; Webster NL; Mukhtar M; Pomerantz RJ; Smythe G; Walker D; Armati PJ; Crowe SM; Brew BJ, 2008, 'Kynurenine pathway metabolism in human blood-brain-barrier cells: Implications for immune tolerance & neurotoxicity', Journal of Neurochemistry, vol. 105, pp. 1346 - 1357, http://dx.doi.org/10.1111/j.1471-4159.2008.05241.x

Wright EJ; Brew BJ; Wesselingh SL, 2008, 'Pathogenesis and Diagnosis of Viral Infections of the Nervous System', Neurologic Clinics, vol. 26, pp. 617 - 633, http://dx.doi.org/10.1016/j.ncl.2008.03.006

Wright E; Brew B; Arayawichanont A; Robertson K; Samintharapanya K; Kongsaengdao S; Lim M; Vonthanak S; Lal L; Sarim C, 2008, 'Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region', Neurology, vol. 71, pp. 50 - 56, http://dx.doi.org/10.1212/01.wnl.0000316390.17248.65

Oldroyd DR, 2008, 'Editor's introduction', Earth Sciences History, vol. 27

Ting KK; Brew BJ; Guillemin GJ, 2008, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease', Neurotoxicity Research, vol. 12, pp. 247 - 262

Brew BJ; Gonzalez-Scarano F, 2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-saharan Africa - Reply from the editorialists', NEUROLOGY, vol. 69, pp. 412 - 413, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000248243300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ; Gonzalez-Scarano F, 2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa [7]', Neurology, vol. 69, pp. 412 - 413, http://dx.doi.org/10.1212/01.wnl.0000278073.28318.66

Brew BJ, 2007, 'Neurological sequelae of primary HIV infection', Handbook of Clinical Neurology, vol. 85, pp. 69 - 77, http://dx.doi.org/10.1016/S0072-9752(07)85005-6

Brew BJ, 2007, 'AIDS dementia complex', Handbook of Clinical Neurology, vol. 85, pp. 79 - 91, http://dx.doi.org/10.1016/S0072-9752(07)85006-8

Brew BJ; Halman M; Catalan J; Sacktor N; Price RW; Brown S; Atkinson H; Clifford DB; Simpson D; Torres G, 2007, 'Factor in AIDS dementia complex trial design: Results and lessons from the abacavir trial', PLoS Clinical Trials, vol. 2, http://dx.doi.org/10.1371/journal.pctr.0020013

Ting KK; Brew B; Guillemin G, 2007, 'The involvement of astrocytes and kynurenine pathway in Alzheimer's disease', Neurotoxicity Research, vol. 12, pp. 247 - 262, http://dx.doi.org/10.1007/BF03033908

Croitoru-Lamoury J; Lamoury FMJ; Zaunders JJ; Veas LA; Brew BJ, 2007, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-β, and copaxone', Journal of Interferon and Cytokine Research, vol. 27, pp. 53 - 64, http://dx.doi.org/10.1089/jir.2006.0037

Gorry PR; McPhee DA; Verity E; Dyer WB; Wesselingh SL; Learmont J; Sullivan JS; Roche M; Zaunders JJ; Gabuzda D, 2007, 'Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo', Retrovirology, vol. 4, http://dx.doi.org/10.1186/1742-4690-4-66

Brew BJ; González-Scarano F, 2007, 'HIV-associated dementia: An inconvenient truth', Neurology, vol. 68, pp. 324 - 325, http://dx.doi.org/10.1212/01.wnl.0000252803.24176.76

Gisslen M; Hagberg L; Rosengren L; Brew BJ; Cinque P; Spudich S; Price RW, 2007, 'Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers', Journal of Neuroimmune Pharmacology, vol. 2, pp. 112 - 119, http://dx.doi.org/10.1007/s11481-006-9035-1

Drake AK; Loy CT; Brew BJ; Chen TCC; Petoumenos K; Li PCK; Wright EJ, 2007, 'Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: Epidemiology and predictive factors for prolonged survival', European Journal of Neurology, vol. 14, pp. 418 - 423, http://dx.doi.org/10.1111/j.1468-1331.2007.01686.x

Thein HH; Maruff P; Krahn M; Kaldor JM; Koorey DJ; Brew BJ; Dore GJ, 2007, 'Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment', HIV Medicine, vol. 8, pp. 192 - 202, http://dx.doi.org/10.1111/j.1468-1293.2007.00452.x

Gisslén M; Hagberg L; Brew BJ; Cinque P; Price RW; Rosengren L, 2007, 'Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex', Journal of Infectious Diseases, vol. 195, pp. 1774 - 1778, http://dx.doi.org/10.1086/518043

Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price RW; Rosengren L; Gisslén M, 2007, 'CSF neurofilament protein (NFL) - A marker of active HIV-related neurodegeneration', Journal of Neurology, vol. 254, pp. 1026 - 1032, http://dx.doi.org/10.1007/s00415-006-0481-8

Brew BJ, 2007, 'Lost in translation: Again, another failed neuroprotection trial', Neurology, vol. 69, pp. 1308 - 1309, http://dx.doi.org/10.1212/01.wnl.0000277530.05450.ff

Brew BJ, 2007, 'HAD and the need for new trial design methodology', AIDS, vol. 21, pp. 1965 - 1966, http://dx.doi.org/10.1097/QAD.0b013e328133850e

Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M, 2007, 'Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection', Neurology, vol. 69, pp. 1536 - 1541, http://dx.doi.org/10.1212/01.wnl.0000277635.05973.55

Antinori A; Arendt G; Becker JT; Brew BJ; Byrd DA; Cherner M; Clifford DB; Cinque P; Epstein LG; Goodkin K, 2007, 'Updated research nosology for HIV-associated neurocognitive disorders', Neurology, vol. 69, pp. 1789 - 1799, http://dx.doi.org/10.1212/01.WNL.0000287431.88658.8b

Guillemin GJ; Brew BJ, 2007, 'Chronic HIV infection leads to an Alzheimer's disease like illness. Involvement of the kynurenine pathway', International Congress Series, vol. 1304, pp. 324 - 334, http://dx.doi.org/10.1016/j.ics.2007.07.031

Thein HH; Maruff P; Krahn MD; Kaldor JM; Koorey DJ; Brew BJ; Dore GJ, 2007, 'Improved cognitive function as a consequence of hepatitis C virus treatment', HIV Medicine, vol. 8, pp. 520 - 528, http://dx.doi.org/10.1111/j.1468-1293.2007.00505.x

Ting KK; Brew BJ; Guillemin GJ, 2007, 'Effect of quinolinic acid on gene expression in human astrocytes: Implications for Alzheimer's disease', International Congress Series, vol. 1304, pp. 384 - 388, http://dx.doi.org/10.1016/j.ics.2007.07.010

Lim CK; Smythe GA; Stocker R; Brew BJ; Guillemin GJ, 2007, 'Characterization of the kynurenine pathway in human oligodendrocytes', International Congress Series, vol. 1304, pp. 213 - 217, http://dx.doi.org/10.1016/j.ics.2007.07.011

Batmanian JJ; Lam M; Matthews C; Finckh A; Duffy M; Wright R; Brew BJ; Markus R, 2007, 'A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department', Medical Journal of Australia, vol. 187, pp. 567 - 570

Guillemin GJ; Cullen KM; Lim CK; Smythe GA; Garner B; Kapoor V; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of Neuroscience, vol. 27, pp. 12884 - 12892, http://dx.doi.org/10.1523/JNEUROSCI.4101-07.2007

Cinque P; Brew BJ; Gisslen M; Hagberg L; Price RW, 2007, 'Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex', Handbook of Clinical Neurology, vol. 85, pp. 261 - 300, http://dx.doi.org/10.1016/S0072-9752(07)85017-2

Guillemin GJ; Brew BJ; Noonan CE; Knight TG; Smythe GA; Cullen KM, 2007, 'Mass spectrometric detection of quinolinic acid in microdissected Alzheimer's disease plaques', International Congress Series, vol. 1304, pp. 404 - 408, http://dx.doi.org/10.1016/j.ics.2007.07.012

Guillemin GJ; Cullen K; Smythe GA; Kapoor V; Lim E; Garner B; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of the History of the Neurosciences, vol. 27, pp. 12884 - 12892

Brew B, 2006, 'Relativity and relativism', NEW SCIENTIST, vol. 188, pp. 27 - 27, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000234329300034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Shah M; Smit TK; Morgello S; Tourtellotte W; Gelman B; Brew BJ; Saksena NK, 2006, 'Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage', AIDS Research and Human Retroviruses, vol. 22, pp. 177 - 181, http://dx.doi.org/10.1089/aid.2006.22.177

Lamoury FMJ; Croitoru-Lamoury J; Brew BJ, 2006, 'Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1', Cytotherapy, vol. 8, pp. 228 - 242, http://dx.doi.org/10.1080/14653240600735875

Churchill MJ; Figueiredo A; Cowley D; Gray L; Purcell DFJ; Sullivan JS; McPhee DA; Wesselingh SL; Brew BJ; Gorry PR, 2006, 'Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-', Journal of NeuroVirology, vol. 12, pp. 219 - 228, http://dx.doi.org/10.1080/13550280600827369

Croitoru-Lamoury J; Williams KR; Lamoury FMJ; Veas LA; Ajami B; Taylor RM; Brew BJ, 2006, 'Neural transplantation of human MSC and NT2 cells in the twitcher mouse model', Cytotherapy, vol. 8, pp. 445 - 458, http://dx.doi.org/10.1080/14653240600879152

Guillemin GJ; Meininger V; Brew BJ, 2006, 'Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis', Neurodegenerative Diseases, vol. 2, pp. 166 - 176, http://dx.doi.org/10.1159/000089622

Cysique LAJ; Maruff P; Darby D; Brew BJ, 2006, 'The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery', Archives of Clinical Neuropsychology, vol. 21, pp. 185 - 194, http://dx.doi.org/10.1016/j.acn.2005.07.011

Cysique LAJ; Maruff P; Brew BJ, 2006, 'The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: A meta-analysis', Journal of the International Neuropsychological Society, vol. 12, pp. 368 - 382, http://dx.doi.org/10.1017/S1355617706060401

Cysique LAJ; Maruff P; Brew BJ, 2006, 'Variable benefit in neuropsychological function in HIV-infected HAART-treated patients', Neurology, vol. 66, pp. 1447 - 1450, http://dx.doi.org/10.1212/01.wnl.0000210477.63851.d3

Cysique LA; Maruff P; Brew BJ, 2006, 'Valproic acid is associated with cognitive decline in HIV-infected individuals: A clinical observational study', BMC Neurology, vol. 6, http://dx.doi.org/10.1186/1471-2377-6-42

Batmanian J; Brew BJ, 2005, 'Clinical significance of central nervous system as sanctuary site for HIV', Journal of HIV therapy, vol. 10, pp. 16 - 21

Guillemin GJ; Cullen KM; Smythe GA; Brew BJ, 2005, 'Involvement of the kynurenine pathway in neuroinflammation', INFLAMMATION RESEARCH, vol. 54, pp. S199 - S199, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600371&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Lamour YJ; Veas LAJ; Lamoury FMJ; Brew BJ, 2005, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors which can be upregulated by cytokines, ifn-beta and copaxone', JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 238, pp. S233 - S233, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088002145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Crowe SM; Ho DD; Marriott D; Brew B; Gorry PR; Sullivan JS; Learmont J; Mills J, 2005, 'In vivo replication kinetics of a nef-deleted strain of HIV-1 [2]', AIDS, vol. 19, pp. 842 - 843, http://dx.doi.org/10.1097/01.aids.0000168984.05209.f1

Brew BJ, 2005, 'HIV associated neurology in the developing world', JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 238, pp. S22 - S22, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Guillemin GJ; Brew BJ; Noonan CE; Knight TG; Smythe G; Callen KM, 2005, 'Mass spectroscopic detection of quinolinic acid in microdissected Alzheimer's disease plaques', INFLAMMATION RESEARCH, vol. 54, pp. S200 - S200, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600374&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew B, 2005, 'HIV related neuromuscular disease', JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 238, pp. S3 - S3, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ, 2005, 'HIV and the nervous system - palliative carte aspects', JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 238, pp. S38 - S38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000158&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Guillemin GJ; Brew BJ; Noonan CE; Takikawa O; Cullen KM, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus', Neuropathology and Applied Neurobiology, vol. 31, pp. 395 - 404, http://dx.doi.org/10.1111/j.1365-2990.2005.00655.x

Berger JR; Brew B, 2005, 'An international screening tool for HIV dementia', AIDS, vol. 19, pp. 2165 - 2166, http://dx.doi.org/10.1097/01.aids.0000194798.66670.6e

Brew B, 2005, 'Relativity and relativism [9]', New Scientist, vol. 188, pp. 27

Winston A; Marriott D; Brew B, 2005, 'Early syphilis presenting as a painful polyradiculopathy in an HIV positive individual', Sexually Transmitted Infections, vol. 81, pp. 133 - 134, http://dx.doi.org/10.1136/sti.2004.011668

Guillemin GJ; Smythe G; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons', GLIA, vol. 49, pp. 15 - 23, http://dx.doi.org/10.1002/glia.20090

McArthur JC; Brew BJ; Nath A, 2005, 'Neurological complications of HIV infection', Lancet Neurology, vol. 4, pp. 543 - 555, http://dx.doi.org/10.1016/S1474-4422(05)70165-4

Brew BJ; Pemberton L; Blennow K; Wallin A; Hagberg L, 2005, 'CSF amyloid β42 and tau levels correlate with AIDS dementia complex', Neurology, vol. 65, pp. 1490 - 1492, http://dx.doi.org/10.1212/01.wnl.0000183293.95787.b7

Guillemin GJ; Kerr SJ; Brew BJ, 2005, 'Involvement of quinolinic acid in aids dementia complex', Neurotoxicity Research, vol. 7, pp. 103 - 123, http://dx.doi.org/10.1007/BF03033781

Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid selectively induces apoptosis of human astocytes: Potential role in AIDS dementia complex', Journal of Neuroinflammation, vol. 2, http://dx.doi.org/10.1186/1742-2094-2-16

Cysique LA; Brew BJ; Halman M; Catalan J; Sacktor N; Price RW; Brown S; Atkinson JH; Clifford DB; Simpson D, 2005, 'Undetectable cerebrospinal fluid HIV RNA and β-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients', Journal of Acquired Immune Deficiency Syndromes, vol. 39, pp. 426 - 429, http://dx.doi.org/10.1097/01.qai.0000165799.59322.f5

Guillemin GJ; Smythe GA; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3 dioxygenase and production of quinolinic acid by human microglia, astrocytes and neurons', Glia, vol. 49, pp. 15 - 23

Guillemin GJ; Brew BJ; Noonan C; Takikawa O; Cullen K, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid in plaque and neurons in post-mortem brain tissue from Alzheimer`s disease and control cases', Neuropathology and Applied Neurobiology, vol. 31, pp. 395 - 404

Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid induces apoptosis of human astrocyte', Journal of Neuroinflammation

Brew BJ, 2004, 'Clinical aspects of AIDS dementia complex in the HAART era', JOURNAL OF NEUROVIROLOGY, vol. 10, pp. 3 - 3, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202992000003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK, 2004, 'Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment', Journal of Virology, vol. 78, pp. 10133 - 10148, http://dx.doi.org/10.1128/JVI.78.18.10133-10148.2004

Brew BJ; Tomlinson SE, 2004, 'HIV neuropathy: Time for new therapies', Drug Discovery Today: Disease Models, vol. 1, pp. 171 - 176, http://dx.doi.org/10.1016/j.ddmod.2004.09.012

Churchill M; Sterjovski J; Gray L; Cowley D; Chatfield C; Learmont J; Sullivan JS; Crowe SM; Mills J; Brew BJ, 2004, 'Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia', Journal of Infectious Diseases, vol. 190, pp. 2181 - 2186, http://dx.doi.org/10.1086/425585

Brew BJ, 2004, 'Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex', AIDS, vol. 18

Guillemin GJ; Brew BJ, 2004, 'Microglia, macrophages, perivascular macrophages, and pericytes: A review of function and identification', Journal of Leukocyte Biology, vol. 75, pp. 388 - 397, http://dx.doi.org/10.1189/jlb.0303114

Brew BJ; Pemberton L; Ray J, 2004, 'Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?', Journal of NeuroVirology, vol. 10, pp. 38 - 43

Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI, 2004, 'Human immunodeficiency virus-related primary central nervous system lymphoma: Factors influencing survival in 111 patients', Cancer, vol. 100, pp. 2627 - 2636, http://dx.doi.org/10.1002/cncr.20300

Brew BJ, 2004, 'HAART in AIDS dementia complex and palliative care', Progress in Palliative Care, vol. 12, pp. 171 - 177, http://dx.doi.org/10.1179/096992604225006370

Cysique LAJ; Maruff P; Brew BJ, 2004, 'Antiretroviral therapy in HIV infection: Are neurologically active drugs important?', Archives of Neurology, vol. 61, pp. 1699 - 1704, http://dx.doi.org/10.1001/archneur.61.11.1699

Cysique LA; Maruff P; Brew BJ, 2004, 'Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretrovira', Journal of NeuroVirology, vol. 10, pp. 350 - 357, http://dx.doi.org/10.1080/13550280490521078

Guillemin GJ; Brew BJ, 2004, 'Phenotypic differences and similarities between microglia, macrophage and pericyte (review)', Journal of Leukocyte Biology, vol. 75, pp. 388 - 397

Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A1-42 induces production of quinolinic acid by human macrophages and microglia', NeuroReport, vol. 14, pp. 165 - 181

Brew BJ; Tisch S; Law M, 2003, 'Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy', AIDS, vol. 17, pp. 1094 - 1096, http://dx.doi.org/10.1097/00002030-200305020-00024

Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A beta 1-42 induces production of quinolinic acid by human macrophages and microglia.', Neuroreport, vol. 14, pp. 2311 - 2315, http://dx.doi.org/10.1097/00001756-200312190-00005

Croitoru-Lamoury J; Guillemin GJ; Boussin FD; Mognetti B; Gigout LI; Chéret A; Vaslin B; Le Grand R; Brew BJ; Dormont D, 2003, 'Expression of chemokines and their receptors in human and simian astrocytes: Evidence for a central role of TNFα and IFNγ in CXCR4 and CCR5 modulation', GLIA, vol. 41, pp. 354 - 370, http://dx.doi.org/10.1002/glia.10181

Guillemin GJ; Croitoru-Lamoury J; Dormont D; Armati PJ; Brew BJ, 2003, 'Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes', GLIA, vol. 41, pp. 371 - 381, http://dx.doi.org/10.1002/glia.10175

Brew BJ, 2003, 'The peripheral nerve complications of human immunodeficiency virus (HIV) infection', Muscle and Nerve, vol. 28, pp. 542 - 552, http://dx.doi.org/10.1002/mus.10484

Croitoru-Lamoury J; Guillemin GJ; Dormont D; Brew BJ, 2003, 'Quinolinic acid up-regulates chemokine production and chemokine receptor expression in astrocytes', Advances in Experimental Medicine and Biology, vol. 527, pp. 37 - 45

Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2003, 'Expression of the kynurenine pathway enzymes in human microglia and macrophages', Advances in Experimental Medicine and Biology, vol. 527, pp. 105 - 112

Guillemin GJ; Williams KR; Smith DG; Smythe GA; Croitoru-Lamoury J; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of alzheimer's disease', Advances in Experimental Medicine and Biology, vol. 527, pp. 167 - 176

Dore GJ; McDonald A; Li Y; Kaldor JM; Brew BJ, 2003, 'Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, vol. 17, pp. 1539 - 1545, http://dx.doi.org/10.1097/00002030-200307040-00015

Guillemin GJ; Croitoru J; Dormont D; Armati PJ; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human fœtal astrocytes', Glia, vol. 41, pp. 371 - 381

Guillemin GJ; Smith DG; Armati PJ; Brew BJ, 2003, 'Expression kynurenine pathway enzymes in human macrophages and microglia', Advances in Experimental Medicine and Biology, vol. 527, pp. 105 - 112

Guillemin GJ; Croitoru-Lamoury J; Dormont D; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human foetal astrocytes', Advances in Experimental Medicine and Biology, vol. 527, pp. 37 - 45

Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A beta I-42 induces production of quinolinic acid by human macrophagesand microglia', Neuroreport, vol. 14, pp. 2311 - 2315

Guillemin GJ; Williams K; Smith DG; Smythe GA; Croitoru-Lamoury J; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of Alzheimer`s disease', Advances in Experimental Medicine and Biology, vol. 527, pp. 167 - 176, http://www.springer.com/series/5584

Brew BJ; Tisch S; Law MG, 2003, 'HIV nucleoside neuropathy and HIV distal symmetrical neuropathy: relationships to serum lactate and plasma HIV viral load', AIDS, vol. 17, pp. 1094 - 1096

Guillemin GJ; Croitoru J; Dormont J; Armati PJ; Brew BJ, 2003, 'Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes: implications for brain inflammation in AIDS', Glia, vol. 41, pp. 371 - 381

Bain M; Brew B; Coltheart M, 2002, 'Progressive peripheral dysgraphia in early posterior cortical atrophy', NEUROBIOLOGY OF AGING, vol. 23, pp. S39 - S40, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000177465300149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Loy CT; Brew BJ, 2002, 'Treatment of opportunistic infections and lymphoma in the nervous system.', Journal of HIV therapy, vol. 7, pp. 21 - 25

Guillemin GJ; Brew BJ, 2002, 'Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease', Redox Report, vol. 7, pp. 199 - 206, http://dx.doi.org/10.1179/135100002125000550

Smythe GA; Braga O; Brew BJ; Grant RS; Guillemin GJ; Kerr SJ; Walker DW, 2002, 'Concurrent quantification of quinolinic, picolinic, and nicotinic acids using electron-capture negative-ion gas chromatography - Mass spectrometry', Analytical Biochemistry, vol. 301, pp. 21 - 26, http://dx.doi.org/10.1006/abio.2001.5490

Loy C; Brew BJ, 2002, 'Lymphona and opportunistic infections of the brain', Journal of Hiv Therapy, vol. 7, pp. 21 - 25

Guillemin GJ; Brew BJ, 2002, 'Implications of the kynurenine pathway and quinolinic acid in Alzheimer`s disease', Redox Report, vol. 7, pp. 1

Smit TK; Wang B; Ng T; Osborne R; Brew B; Saksena NK, 2001, 'Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): Evidence for neurotropic HIV variants', Virology, vol. 279, pp. 509 - 526, http://dx.doi.org/10.1006/viro.2000.0681

Lanier ER; Sturge G; McClernon D; Brown S; Halman M; Sacktor N; McArthur J; Atkinson JH; Clifford D; Price RW, 2001, 'HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir', AIDS, vol. 15, pp. 747 - 751, http://dx.doi.org/10.1097/00002030-200104130-00010

Pemberton LA; Brew BJ, 2001, 'Cerebrospinal fluid S-100β and its relationship with AIDS dementia complex', Journal of Clinical Virology, vol. 22, pp. 249 - 253, http://dx.doi.org/10.1016/S1386-6532(01)00196-2

Smith DG; Guillemin GJ; Pemberton L; Kerr S; Nath A; Smythe GA; Brew BJ, 2001, 'Quinolinic acid is produced by macrophages stimulated platelet activating factor, Nef and Tat', Journal of NeuroVirology, vol. 7, pp. 56 - 60, http://dx.doi.org/10.1080/135502801300069692

Guillemin GJ; Kerr SJ; Pemberton LA; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2001, 'IFN-β 1binduces kynurenine pathway metabolism in human macrophages: Potential implications for multiple sclerosis treatment', Journal of Interferon and Cytokine Research, vol. 21, pp. 1097 - 1101, http://dx.doi.org/10.1089/107999001317205231

Brew BJ, 2001, 'HTLV-I and HIV infections of the CNS in tropical areas [10]', Journal of Neurology Neurosurgery and Psychiatry, vol. 70, pp. 138, http://dx.doi.org/10.1136/jnnp.70.1.138

Brew BJ, 2001, 'Markers of AIDS dementia complex: The role of cerebrospinal fluid assays', AIDS, vol. 15, pp. 1883 - 1884, http://dx.doi.org/10.1097/00002030-200109280-00020

Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ, 2001, 'Kynurenine pathway metabolism in human astrocytes: A paradox for neuronal protection', Journal of Neurochemistry, vol. 78, pp. 842 - 853, http://dx.doi.org/10.1046/j.1471-4159.2001.00498.x

Brew BJ, 2000, 'Does HHV-8 have a neuroprotective role on the development of HIV encephalopathy? [6] (multiple letters)', Neurology, vol. 55, pp. 459 - 460, http://dx.doi.org/10.1212/WNL.55.3.459-a

Brew BJ; Dore G, 2000, 'Decreasing incidence of CNS AIDS defining events associated with antiretroviral therapy [7] (multiple letters)', Neurology, vol. 55, pp. 1424, http://dx.doi.org/10.1212/WNL.55.9.1424

Dore G; Brew B, 2000, 'Response to Eberly et al., Kaposi's sarcoma and central nervous system disease: A real association or an artifact of the control group? [1]', AIDS, vol. 14, pp. 2631 - 2632, http://dx.doi.org/10.1097/00002030-200011100-00037

Guillemin GJ; Kerr SJ; Smythe GA; Armati PJ; Brew BJ, 2000, 'Kynurenine pathway metabolism in human astrocytes', Advances in Experimental Medicine and Biology, vol. 467, pp. 125 - 131

Grulich AE; Dore GJ; Brew BJ, 2000, 'Human herpesvirus 8 and protection from AIDS dementia complex', Herpes, vol. 7, pp. 38 - 40

Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati PJ; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis', Redox Report, vol. 5, pp. 108 - 111, http://dx.doi.org/10.1179/135100000101535375

Cunningham PH; Smith DG; Satchell C; Cooper DA; Brew B, 2000, 'Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid', AIDS, vol. 14, pp. 1949 - 1954, http://dx.doi.org/10.1097/00002030-200009080-00010

Guillemin GJ; Smith DD; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neutopathogenesis', Redox Report, pp. 108 - 111

Brew BJ, 1999, 'AIDS dementia complex', Neurologic Clinics, vol. 17, pp. 861 - 881, http://dx.doi.org/10.1016/S0733-8619(05)70170-5

Brennan JW; Pell MF; Brew BJ, 1999, 'HIV-related primary cerebral lymphoma: The role of stereotactic biopsy', Journal of Clinical Neuroscience, vol. 6, pp. 217 - 220, http://dx.doi.org/10.1016/S0967-5868(99)90506-4

Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ, 1999, 'Changes to AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, vol. 13, pp. 1249 - 1253, http://dx.doi.org/10.1097/00002030-199907090-00015

Kerr SJ; Pemberton LA; Guillemin GJ; Smythe G; Brew BJ, 1998, 'Interferon-beta induces kynurenine pathway metabolism inhuman macrophages', NEUROLOGY, vol. 50, pp. A34 - A34, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000073240900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Goldman HB; Gildenberg PL; Brew BJ; Antinori A; Berger JR, 1998, 'Evaluation and management of intracranial mass lesions in AIDS: Report of the Quality Standards Subcommittee of the American Academy of Neurology [2] (multiple letters)', Neurology, vol. 51, pp. 1232 - 1234

Dore GJ; Grulich A; Law MG; Brew BJ; Kaldor JM, 1998, 'Kaposi's sarcoma and protection from AIDS dementia complex [4]', AIDS, vol. 12, pp. 2354 - 2355

Brew BJ, 1998, 'Neurological efficacy of stavudine, zidovudine, and lamivudine.', Lancet, vol. 352, pp. 402, http://dx.doi.org/10.1016/S0140-6736(05)60498-9

Brew BJ; Gisslen M; Svennerholm B; Fuchs D; Hagberg L, 1998, 'Neurological efficacy of stavudine, zidovudine, and lamivudine (multiple letters) [2]', Lancet, vol. 352, pp. 402 - 403

Szeto ER; Freund J; Brew BJ; Loder A; Griffiths MR, 1998, 'Cerebral perfusion scanning in treating AIDS dementia: A pilot study', Journal of Nuclear Medicine, vol. 39, pp. 298 - 302

Kerr SJ; Armati PJ; Guillemin GJ; Brew BJ, 1998, 'Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex', AIDS, vol. 12, pp. 355 - 363, http://dx.doi.org/10.1097/00002030-199804000-00003

Markus R; Brew BJ, 1998, 'HIV-1 peripheral neuropathy and combination antiretroviral therapy', Lancet, vol. 352, pp. 1906 - 1907, http://dx.doi.org/10.1016/S0140-6736(05)60397-2

McPhee DA; Greenway AL; Holloway G; Smith K; Deacon N; Pemberton L; Brew BJ, 1998, 'Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex', Journal of NeuroVirology, vol. 4, pp. 291 - 300, http://dx.doi.org/10.3109/13550289809114530

Dunbar N; Brew B, 1997, 'Neuropsychological Dysfunction in HIV Infection:A Review', Journal of neuro-AIDS, vol. 1, pp. 73 - 102

Kerr SJ; Armati PJ; Pemberton LA; Smythe G; Brew BJ, 1997, 'Kynurenine pathway inhibition with 6-chloro-D-tryptophan reduces neurotoxicity of HIV-1 infected macrophage supernatants', NEUROLOGY, vol. 48, pp. 2008 - 2008, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XG87100226&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Dore GJ; Law MG; Brew BJ, 1997, 'Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection', Journal of Neuro-AIDS, vol. 1, pp. 59 - 69, http://dx.doi.org/10.1300/J128v01n04_06

Dunbar N; Pemberton L; Perdices M; Brew BJ, 1997, 'Clinical markers of the presence of dementia and neuropsychological impairment in hiv infection', Journal of Neuro-AIDS, vol. 1, pp. 31 - 48, http://dx.doi.org/10.1300/J128v01n04_04

Pemberton LA; Kerr SJ; Brew BJ, 1997, 'HIV-1 gp120 does not induce Quinolinic acid production by macrophages.', Journal of neurovirology, vol. 3, pp. 86 - 87, http://dx.doi.org/10.3109/13550289709015798

Bradley TP; Brew BJ, 1997, 'HIV type-1-related transient neurologic deficits [2] (multiple letters)', American Journal of Medicine, vol. 103, pp. 250

Markus R; Brew BJ; Turner J; Pell M, 1997, 'Successful outcome with aggressive treatment of acute haemorrahagic leukoencephalitis [2]', Journal of Neurology Neurosurgery and Psychiatry, vol. 63, pp. 551, http://dx.doi.org/10.1136/jnnp.63.4.551

Brew BJ; Pemberton L; Cunningham P; Law MG, 1997, 'Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage', Journal of Infectious Diseases, vol. 175, pp. 963 - 966, http://dx.doi.org/10.1086/514001

Dick AD; Pell M; Brew BJ; Foulcher E; Sedgwick JD, 1997, 'Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: Examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurologi', AIDS, vol. 11, pp. 1699 - 1708, http://dx.doi.org/10.1097/00002030-199714000-00006

Brew BJ, 1997, 'The cellular basis of central nervous HIV-1 infection and the AIDS dementia complex - Price,RW, Sidtis,JJ', VENEREOLOGY-THE INTERDISCIPLINARY INTERNATIONAL JOURNAL OF SEXUAL HEALTH, vol. 10, pp. 126 - 126, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XV34400011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ, 1997, 'HIV type-1-related transient neurologic deficits - Reply', AMERICAN JOURNAL OF MEDICINE, vol. 103, pp. 250 - 251, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XX32200012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Cunningham AL; Naif H; Saksena N; Lynch G; Chang J; Li S; Jozwiak R; Alali M; Wang B; Fear W, 1997, 'HIV infection of macrophages and pathogenesis of AIDS dementia complex: Interaction of the host cell and viral genotype', Journal of Leukocyte Biology, vol. 62, pp. 117 - 125, http://dx.doi.org/10.1002/jlb.62.1.117

Kerr SJ; Armati PJ; Pemberton LA; Smythe G; Tattam B; Brew BJ, 1997, 'Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages', Neurology, vol. 49, pp. 1671 - 1681, http://dx.doi.org/10.1212/WNL.49.6.1671

Adcock JE; Davies MA; Turner J; Pell M; Brew BJ, 1997, 'Progressive multifocal leukoencephalopathy: A retrospective study of 30 cases', Journal of Clinical Neuroscience, vol. 4, pp. 463 - 468, http://dx.doi.org/10.1016/S0967-5868(97)90036-9

Pemberton LA; Kerr SJ; Smythe G; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulated with IFN-γ, TNF- α, and IFN-α', Journal of Interferon and Cytokine Research, vol. 17, pp. 589 - 595, http://dx.doi.org/10.1089/jir.1997.17.589

Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulate with interferon y tumour necrosis factor a and interferon a', Journal of Interferon and Cytokine Research, vol. 17, pp. 589 - 595

Jones PD; Beaman MH; Brew BJ, 1996, '5.5 HIV and opportunistic neurological infections', Medical Journal of Australia, vol. 164, pp. 418 - 421

Dunbar N; Brew B, 1996, 'Neuropsychological dysfunction in HIV infection: A review', Journal of Neuro-AIDS, vol. 1, pp. 73 - 102, http://dx.doi.org/10.1300/J128v01n03_05

Jones PD; Beaman MH; Brew BJ, 1996, 'Managing HIV. Part 5: Treating secondary outcomes. 5.5 HIV and opportunistic neurological infections.', Med J Aust, vol. 164, pp. 418 - 421, https://www.ncbi.nlm.nih.gov/pubmed/8609854

Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'How HIV leads to neurological disease', Medical Journal of Australia, vol. 164, pp. 233 - 234

Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease.', Med J Aust, vol. 164, pp. 233 - 234, https://www.ncbi.nlm.nih.gov/pubmed/8604196

Wright EJ; Brew BJ; Currie JN; McArthur JC, 1996, 'Managing HIV. Part 5: Treating secondary outcomes. 5.4 HIV-induced neurological disease.', Med J Aust, vol. 164, pp. 414 - 417, https://www.ncbi.nlm.nih.gov/pubmed/8609853

Wright EJ; Brew BJ; Currie JN; McArthur JC, 1996, '5.4 HIV-induced neurological disease', Medical Journal of Australia, vol. 164, pp. 414 - 417

Brew BJ; Glass JD; McArthur JC, 1996, 'Human immunodeficiency virus in brain and correlation with dementia [5]', Annals of Neurology, vol. 39, pp. 828 - 829, http://dx.doi.org/10.1002/ana.410390631

Brew BJ; Miller J, 1996, 'Human immunodeficiency virus type 1-related transient neurological deficits', American Journal of Medicine, vol. 101, pp. 257 - 261, http://dx.doi.org/10.1016/S0002-9343(96)00123-4

Brew BJ; Dunbar N; Druett JA; Freund J; Ward P, 1996, 'Pilot study of the efficacy of atevirdine in the treatment of AIDS dementia complex', AIDS, vol. 10, pp. 1357 - 1360, http://dx.doi.org/10.1097/00002030-199610000-00007

Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection', Journal of Neurology Neurosurgery and Psychiatry, vol. 61, pp. 606 - 609, http://dx.doi.org/10.1136/jnnp.61.6.606

Field AS; Marriott DJ; Milliken ST; Brew BJ; Canning EU; Kench JG; Darveniza P; Harkness JL, 1996, 'Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS', Journal of Clinical Microbiology, vol. 34, pp. 2803 - 2811

Brew BJ; Evans L; Byrne C; Pemberton L; Hurren L, 1996, 'The relationship between AIDS dementia complex and the presence of macrophage tropic and non syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid', Journal of NeuroVirology, vol. 2, pp. 152 - 157, http://dx.doi.org/10.3109/13550289609146877

Brew BJ; Dunbar N; Druett J; Freund J; Ward PB, 1996, 'Pilot study of the efficacy of atervidine in ADC', AIDS, vol. 10, pp. 1357 - 1360

Brew BJ; Corbeil J; Pemberton LA; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1996, 'Quinolinic acid production by macrophages infected with HIV-1 isolates from patients with and without AIDS dementia complex', Journal of Neurovirology, vol. 1, pp. 369 - 374

Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'An association between HIV distal symmetrical polyneuropathy and Mycobacterium Avium complex infection', Journal of Neurology Neurosurgery and Psychiatry, pp. 606 - 609

Davies MA; Pell MF; Brew BJ, 1995, 'Stereotactic biopsy of cerebral lesions in acquired immunodeficiency syndrome', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44, http://dx.doi.org/10.1016/0967-5868(95)90028-4

Brew BJ; Rosenblum M; Cronin K; Price RW, 1995, 'AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlations', Annals of Neurology, vol. 38, pp. 563 - 570, http://dx.doi.org/10.1002/ana.410380404

Brew BJ; Corbeil J; Pemberton L; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1995, 'Quinolinic acid production is related to macrophage tropic isolates of HIV-1.', Journal of neurovirology, vol. 1, pp. 369 - 374, http://dx.doi.org/10.3109/13550289509111026

Kerr SJ; Armati PJ; Brew BJ, 1995, 'Neurocytotoxity of quinolinic acid in human brain cultures.', Journal of neurovirology, vol. 1, pp. 375 - 380, http://dx.doi.org/10.3109/13550289509111027

Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotactic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44

Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotectic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44

Brew BJ; Rosenblum M; Cronin K; Price R, 1995, 'The AIDS dementia complex and human immunodeficiency virus type 1 brian infection: clinical-virological correlations', Annals of Neurology, pp. 563 - 570

Brew BJ, 1994, 'Optimal Treatment of HIV-1-Induced CNS Neurological Disorders', CNS Drugs, vol. 2, pp. 292 - 300, http://dx.doi.org/10.2165/00023210-199402040-00005

Brew BJ; Paul MO; Nakajima G; Khan A; Gallardo H; Price RW, 1994, 'Cerebrospinal fluid HIV-1 p24 antigen and culture: Sensitivity and specificity for AIDS-dementia complex', Journal of Neurology, Neurosurgery and Psychiatry, vol. 57, pp. 784 - 789, http://dx.doi.org/10.1136/jnnp.57.7.784

Brew BJ, 1994, 'HIV dementia', Neurology, vol. 44, pp. 2214

Clezy K; Sirisanthana T; Sirisanthana V; Brew B; Cooper DA, 1994, 'Late manifestations of HIV in Asia and the Pacific', AIDS, vol. 8

Brew BJ, 1994, 'The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy', Current Opinion in Neurology, vol. 7, pp. 209 - 216, http://dx.doi.org/10.1097/00019052-199406000-00006

Milstien S; Sakai N; Brew BJ; Krieger C; Vickers JH; Saito K; Heyes MP, 1994, 'Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases', Journal of Neurochemistry, vol. 63, pp. 1178 - 1180

Kelleher AD; Brew BJ; Milliken ST, 1994, 'Intractable headache as the presenting complaint of AIDS-related lymphoma confined to bone', Journal of Acquired Immune Deficiency Syndromes, vol. 7, pp. 629 - 630

Brew BJ, 1993, 'The pathogenesis of the neurological complications of HIV-1 infection', Genitourinary Medicine, vol. 69, pp. 333 - 340

Brew BJ; Miller J, 1993, 'Human immunodeficiency virus-related headache', Neurology, vol. 43, pp. 1098 - 1100

Brew BJ; Currie JN, 1993, 'HIV-related neurological disease', Medical Journal of Australia, vol. 158, pp. 104 - 108

Quinn D; Pocock N; Freund J; Kelleher A; Penny R; Brew B, 1993, 'Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis', Clinical Nuclear Medicine, vol. 18, pp. 417 - 422, http://dx.doi.org/10.1097/00003072-199305000-00010

BREW BJ; CURRIE JN, 1993, 'COULD IT BE HIV .8. HIV-RELATED NEUROLOGICAL DISEASE', MEDICAL JOURNAL OF AUSTRALIA, vol. 158, pp. 104 - 108, http://dx.doi.org/10.5694/j.1326-5377.1993.tb137536.x

Brew BJ; Perdices M, 1992, 'HIV nomenclature', Neurology, vol. 42, pp. 265, http://dx.doi.org/10.1212/WNL.42.1.265

Brew BJ, 1992, 'Central and peripheral nervous system abnormalities', Medical Clinics of North America, vol. 76, pp. 63 - 81, http://dx.doi.org/10.1016/S0025-7125(16)30371-6

Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP, 1992, 'Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and β 2 -microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients', Journal of Neuroimmunology, vol. 40, pp. 71 - 80, http://dx.doi.org/10.1016/0165-5728(92)90214-6

Brew BJ, 1992, 'Medical management of AIDS patients. Central and peripheral nervous system abnormalities.', Med Clin North Am, vol. 76, pp. 63 - 81, https://www.ncbi.nlm.nih.gov/pubmed/1727542

Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW, 1992, 'Cerebrospinal fluid β2-microglobulin in patients with AIDS dementia complex: An expanded series including response to zidovudine treatment', AIDS, vol. 6, pp. 461 - 465

Rosenblum MK; Brew BJ; Hahn B; Shaw G; Haase A; Maroushek S; Price RW, 1992, 'Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome', Human Pathology, vol. 23, pp. 513 - 519, http://dx.doi.org/10.1016/0046-8177(92)90128-P

Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA, 1992, 'Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS', Annals of Internal Medicine, vol. 117, pp. 106 - 111, http://dx.doi.org/10.7326/0003-4819-117-2-106

Shaskan EG; Brew BJ; Rosenblum M; Thompson RM; Price RW, 1992, 'Increased Neopterin Levels in Brains of Patients with Human Immunodeficiency Virus Type 1 Infection', Journal of Neurochemistry, vol. 59, pp. 1541 - 1546, http://dx.doi.org/10.1111/j.1471-4159.1992.tb08471.x

KAPLAN JE; LITCHFIELD B; ROUAULT C; LAIRMORE MD; LUO CC; WILLIAMS L; BREW BJ; PRICE RW; JANSSEN R; STONEBURNER R, 1991, 'HTLV-I ASSOCIATED MYELOPATHY ASSOCIATED WITH BLOOD-TRANSFUSION IN THE UNITED-STATES - EPIDEMIOLOGIC AND MOLECULAR EVIDENCE LINKING DONOR AND RECIPIENT', NEUROLOGY, vol. 41, pp. 192 - 197, http://dx.doi.org/10.1212/WNL.41.2_Part_1.192

Kaplan JE; Litchfield B; Rouault C; Lairmore MD; Luo CC; Williams L; Brew BJ; Price RW; Janssen R; Stoneburner R, 1991, 'HTLV-I—associated myelopathy associated with blood transfusion in the United States: Epidemiologic and molecular evidence linking donor and recipient', Neurology, vol. 41, pp. 192 - 197

Janssen RS; Kaplan JE; Khabbaz RF; Hammond R; Lechtenberg R; Lairmore M; Chiasson MA; Punsalang A; Roberts B; Mc Kendall RR, 1991, 'HTLV–I—associated myelopathy/tropical spastic paraparesis in the United States', Neurology, vol. 41, pp. 1355 - 1357

Heyes MP; Brew BJ; Martin A; Price RW; Salazar AM; Sidtis JJ; Yergey JA; Mouradian MM; Sadler AE; Keilp J, 1991, 'Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status', Annals of Neurology, vol. 29, pp. 202 - 209, http://dx.doi.org/10.1002/ana.410290215

Brew BJ, 1991, 'MS-like leukoencephalopathy in HIV-1', Neurology, vol. 41, pp. 1166, http://dx.doi.org/10.1212/WNL.41.7.1166-a

Heyes MP; Brew B; Martin A; Markey SP; Price RW; Bhalla RB; Salazar A, 1991, 'Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome', Advances in Experimental Medicine and Biology, vol. 294, pp. 687 - 690

Kaplan JE; Litchfield B; Rouault C; Lairmore MD; Luo CC; Williams L; Brew BJ; Price RW; Janssen R; Stoneburner R, 1991, 'HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient.', Neurology, vol. 41, pp. 192 - 197, https://www.ncbi.nlm.nih.gov/pubmed/1992361

Reimund E; Martin AA; Emerich DF; Sanberg PR; James Brew B; Everall I; Luthert P; Lantos P, 1991, 'Neuronal loss in frontal cortex in HIV infection', The Lancet, vol. 338, pp. 129 - 130, http://dx.doi.org/10.1016/0140-6736(91)90131-8

Portegies P; Brew BJ, 1991, 'Update on HIV-related neurological illness.', AIDS (London, England), vol. 5 Suppl 2

Price RW; Sidtis JJ; Brew BJ, 1991, 'AIDS Dementia Complex and HIV‐1 Infection: A View From the Clinic', Brain Pathology, vol. 1, pp. 155 - 162, http://dx.doi.org/10.1111/j.1750-3639.1991.tb00655.x

Brew BJ; Cooper DA, 1991, 'Neurological manifestations of HIV-1 infection [10]', AIDS, vol. 5, pp. 609, http://dx.doi.org/10.1097/00002030-199105000-00030

BREW BJ, 1990, 'REPLY', Australian and New Zealand Journal of Medicine, vol. 20, pp. 630 - 630, http://dx.doi.org/10.1111/j.1445-5994.1990.tb01333.x

Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW, 1990, 'Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection', Annals of Neurology, vol. 28, pp. 556 - 560, http://dx.doi.org/10.1002/ana.410280413

Krown SE; Gold JWM; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ, 1990, 'Interferon-α with zidovudine: Safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)', Annals of Internal Medicine, vol. 112, pp. 812 - 821, http://dx.doi.org/10.7326/0003-4819-112-11-812

Price RW; Brew BJ; Rosenblum M, 1990, 'The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction.', Research publications - Association for Research in Nervous and Mental Disease, vol. 68, pp. 269 - 290

BREW BJ, 1990, 'Prognosis of patients … myelopathy of unknown origin', Australian and New Zealand Journal of Medicine, vol. 20, pp. 189 - 189, http://dx.doi.org/10.1111/j.1445-5994.1990.tb01303.x

ROSENBLUM M; SCHECK A; CRONIN K; KHAN A; PAUL M; BREW B; PRICE RW, 1989, 'DISSOCIATION OF VACUOLAR MYELOPATHY AND DETECTABLE HIV-1 INFECTION OF THE SPINAL-CORD', LABORATORY INVESTIGATION, vol. 60, pp. A80 - A80, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1989R895900485&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ; Bhalla RB; Fleisher M; Paul M; Khan A; Schwartz MK; Price RW, 1989, 'Cerebrospinal fluid β<inf>2</inf>microglobulin in patients infected with human immunodeficiency virus', Neurology, vol. 39, pp. 830 - 834

Brew BJ; Hardy W; Zuckerman E; Chien N; Paul M; Rosenblum M; Gadler H; Vahlne A; Gold J; Armstrong DA, 1989, 'AIDS‐related vacuolar myelopathy is not associated with coinfection by human T‐lymphotropic virus Type I', Annals of Neurology, vol. 26, pp. 679 - 681, http://dx.doi.org/10.1002/ana.410260515

Rosenblum M; Scheck AC; Cronin K; Brew BJ; Khan A; Pau M; Price RW, 1989, 'Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord', Neurology, vol. 39, pp. 892 - 896

Brew BJ, 1989, 'Acute encephalopathy caused by human immunodeficiency virus apparently responsive to zidovudine', Medical Journal of Australia, vol. 151, pp. 725 - 726

BREW BJ; PERDICES M; DARVENIZA P; EDWARDS P; WHYTE B; BURKE WJ; GARRICK R; O'SULLIVAN D; PENNY R; COOPER DA, 1989, 'THE NEUROLOGICAL FEATURES OF EARLY AND ‘LATENT’ HUMAN IMMUNODEFICIENCY VIRUS INFECTION', Australian and New Zealand Journal of Medicine, vol. 19, pp. 700 - 705, http://dx.doi.org/10.1111/j.1445-5994.1989.tb00339.x

Price RW; Brew B; Sidtis J; Rosenblum M; Scheck AC; Cleary P, 1988, 'The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex', Science, vol. 239, pp. 586 - 592, http://dx.doi.org/10.1126/science.3277272

Brew BJ; Price RW, 1988, 'Another Retroviral Disease of the Nervous System', New England Journal of Medicine, vol. 318, pp. 1195 - 1197, http://dx.doi.org/10.1056/NEJM198805053181809

Price RW; Brew B, 1988, 'Management of the neurologic complications of HIV infection and AIDS.', Infectious disease clinics of North America, vol. 2, pp. 359 - 372

Brew BJ; Sidtis JJ; Rosenblum M; Price RW, 1988, 'AIDS dementia complex', Journal of the Royal College of Physicians of London, vol. 22, pp. 140 - 144

HOUANG MTW; STERN M; BREW B; PELL M; SHEEHY J, 1988, 'Magnetic Resonance Imaging (MRI) of Pseudosyrinxes', Australasian Radiology, vol. 32, pp. 178 - 183, http://dx.doi.org/10.1111/j.1440-1673.1988.tb02718.x

Price RW; Brew BJ, 1988, 'The aids dementia complex', Journal of Infectious Diseases, vol. 158, pp. 1079 - 1083, http://dx.doi.org/10.1093/infdis/158.5.1079

Brew BJ; Rosenblum M; Price RW, 1988, 'Pathogenetic implications of neuropathological findings in the AIDS dementia complex', Psychopharmacology Bulletin, vol. 24, pp. 307 - 310

Aronow HA; Brew BJ; Price RW, 1988, 'The management of the neurological complications of HIV infection and AIDS', AIDS, vol. 2

PRICE RW; BREW B, 1988, 'Infection of the Central Nervous System by Human Immunodeficiency Virus Role of the Immune System in Pathogenesis', Annals of the New York Academy of Sciences, vol. 540, pp. 162 - 175, http://dx.doi.org/10.1111/j.1749-6632.1988.tb27059.x

Brew BJ; Rosenblum M; Price RW, 1988, 'AIDS dementia complex and primary HIV brain infection', Journal of Neuroimmunology, vol. 20, pp. 133 - 140, http://dx.doi.org/10.1016/0165-5728(88)90144-0

HOUANG MTW; STERN M; BREW B; PELL M; DARVENIZA P, 1988, 'Magnetic Resonance Imaging (MRI) Appearances of Syringohydromyelia', Australasian Radiology, vol. 32, pp. 172 - 177, http://dx.doi.org/10.1111/j.1440-1673.1988.tb02717.x

Brew BJ; Garrick R, 1987, 'Gliomas presenting outside the central nervous system.', Clinical and experimental neurology, vol. 23, pp. 111 - 117

Brew BJ; Garrick R; Connelley TJ, 1987, 'Lumboperitoneal shunting as a cause of visual loss in benign intracranial hypertension.', Clinical and experimental neurology, vol. 23, pp. 233 - 235

Brew BJ; O'Sullivan DJ; Darveniza P; Selby G; Fryer J; Evans W, 1987, 'Neoplastic angioendotheliosis.', Clinical and experimental neurology, vol. 23, pp. 119 - 126

BREW BJ, 1986, 'DIAGNOSIS OF WERNICKE'S ENCEPHALOPATHY', Australian and New Zealand Journal of Medicine, vol. 16, pp. 676 - 678, http://dx.doi.org/10.1111/j.1445-5994.1986.tb00011.x

Tuck RR; Brew BJ; Britton AM; Loewy J, 1984, 'Alcohol and Brain Damage', British Journal of Addiction, vol. 79, pp. 251 - 259, http://dx.doi.org/10.1111/j.1360-0443.1984.tb00273.x

Lim CK; Stankovic RK; Wu W; Adams S; Brew BJ; Guillemin GJ, 2012, 'Involvement of the Kynurenine Pathway in Multiple Sclerosis Progression: the Link between Neuroinflammation and Neurodegeneration', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Singapore, SINGAPORE, pp. 534 - 535, presented at 4th Congress of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), Singapore, SINGAPORE, 28 - 30 August 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302289900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Clifford D; Nath A; Cinque P; Brew BJ; Workman A; Gorelik L; Zhao J; Duda P, 2011, 'Mefloquine Treatment in Patients with Progressive Multifocal Leukoencephalopathy (PML)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Honolulu, HI, pp. A28 - A28, presented at 63rd AAN Annual Meeting, Honolulu, HI, 09 - 16 April 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288149300095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Kandanearatchi A; Wilkinson J; Seddiki N; Zaunders J; Cunningham A; Brew BJ, 2010, 'Neurotropic HIV-1 viruses induce the Kynurenine Pathway (KP) more effectively compared to non-neurotropic viruses in monocyte derived dendritic cells (MDDCs)', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Milan, ITALY, pp. 43 - 43, presented at 10th International Symposium on NeuroVirology, Milan, ITALY, 12 - 16 October 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283409800094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Cysique LA; Myung-Lee J; Lane T; Moffat K; Davies N; Carr A; Brew BJ; Rae C, 2010, 'Glutamate excitotoxicity, cortical and subcortical neuronal damage as potential markers of HIV-associated neurocognitive disorder (HAND): A 1H-MRS and neuropsychological study', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Milan, ITALY, pp. 22 - 23, presented at 10th International Symposium on NeuroVirology, Milan, ITALY, 12 - 16 October 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283409800048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Cysique LA; Moffat K; Fox E; Brew BJ; Rae CD, 2010, 'Frontal white matter and Posterior Cingulate abnormalities metabolite abnormalities in older and clinically stable HIV+ individuals', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, pp. 67 - 67, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January - 03 February 2010

Tisch S; Brew BJ, 2009, 'Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', in MOVEMENT DISORDERS, WILEY-LISS, Paris, FRANCE, pp. S425 - S425, presented at 13th International Congress of Parkinsons Disease and Movement Disorders, Paris, FRANCE, 07 - 11 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266618101505&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Pemberton LA; Sterjovski J; Ramsland P; Gorry PR; Brew BJ, 2009, 'Altered Structural Conformation of the V3 Region between CSF Isolates from HAD and Non-HAD Individuals: Implications for Co-Receptor Usage', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 71 - 72, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Gray LR; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherrief S; Wang B; Saksena N; Purcell DFJ, 2009, 'Tissue-specific sequence alterations in the HIV-1 envelope favoring CCR5-usage contribute to persistence of dual-tropic virus in brain', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 31 - 32, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Pemberton LA; Thompson K; Churchill M; Guillemin G; Gorry PR; Wesselingh S; Brew BJ, 2009, 'Mechanism for involvement of S-100 beta in HIV associated dementia', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 72 - 72, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Cysique LA; Maruff P; Wright E; Brew BJ, 2009, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 19 - 20, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Cysique LA; Brew BJ, 2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, Miami Beach, FL, pp. 19 - 19, presented at 9th International Symposium on NeuroVirology, Miami Beach, FL, 02 - 06 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Clifford D; Brew B; Cinque P; Gorelik L; Bennett D; Panzara MA; Duda P; Nath A, 2009, 'Design of a clinical trial of mefloquine in patients with progressive multifocal leukoencephalopathy', in MULTIPLE SCLEROSIS, SAGE PUBLICATIONS LTD, Dusseldorf, GERMANY, pp. S87 - S87, presented at 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Dusseldorf, GERMANY, 09 - 12 September 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269652500255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Cysique LA; Maruff P; Wright E; Brew BJ, 2009, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P43 - P43, presented at Petrophysics, 01 January 2008

Cysique LA; Brew BJ, 2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P42 - P42, 01 January 2009

Guillemin GJ; Cullen KM; Smythe GA; Lim CK; Garner B; Brew BJ, 2008, 'Characterization of the kynurenine pathway in human primary neurons', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 78 - 78, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 - 30 January 2008

Brew BJ; Pemberton L; Thompson K; Gorry P; Wesselingh S, 2007, 'S-100b: Role in the pathogenesis of HIV associated dementia (HAD)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, Boston, MA, pp. A140 - A140, presented at 59th Annual Meeting of the American-Academy-of-Neurology, Boston, MA, 28 April - 05 May 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245175001043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Cinque P; Sidenius N; Bestetti A; Sala S; Lazzarin A; Brew BJ; Gisslen M-N; Hagberg L; Price RW, 2007, 'Cerebrospinal fluid (CSF) soluble urokinase plasminogen activator (uPA) receptor (suPAR) in AIDS dementia complex, and its relationships with other uPA, virological, immuneactivation and neuronal CSF', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, San Diego, CA, pp. 6 - 6, presented at 8th International Symposium on Neurovirology, San Diego, CA, 30 October - 02 November 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250754000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Kandanearatchi A; Guillemin G; Wilkinson J; Cunningham A; Brew B, 2007, 'The kynurenine pathway metabolite quinolinic acid upregulates CCR5 expression', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, San Diego, CA, pp. 91 - 91, presented at 8th International Symposium on Neurovirology, San Diego, CA, 30 October - 02 November 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250754000172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ; Cysique LA; Maruff P, 2006, 'Variable benefit in neuropsychological function in HIV infected HAART-treated patients', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, San Diego, CA, pp. A257 - A257, presented at 58th Annual Meeting of the American-Academy-of-Neurology, San Diego, CA, 01 - 08 April 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000236068103065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ, 1997, 'AIDS dementia complex and its prevention', in Antiviral Therapy, pp. 69 - 73

Brew BJ; Dunbar N; Pemberton L; Kaldor J, 1996, 'Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of β2-microglobulin and neopterin', in Journal of Infectious Diseases, pp. 294 - 298, http://dx.doi.org/10.1093/infdis/174.2.294

Brew BJ, 1993, 'HIV-1-related neurological disease', in Journal of Acquired Immune Deficiency Syndromes, pp. S10 - S15

Sweeney JA; Brew BJ; Keilp JG; Sidtis JJ; Price RW, 1991, 'Pursuit eye movement dysfunction in HIV-1 seropositive individuals.', in Journal of psychiatry & neuroscience : JPN, pp. 247 - 252

HEYES MP; BREW BJ; PRICE RW; MARKEY SP, 1990, 'CEREBROSPINAL-FLUID QUINOLINIC ACID AND KYNURENIC ACID IN HIV-1 INFECTION', in GUIDOTTI A (ed.), NEUROTOXICITY OF EXCITATORY AMINO ACIDS, RAVEN PRESS, SCOTTSDALE, AZ, pp. 217 - 221, presented at SYMP ON NEUROTOXICITY OF EXCITATORY AMINO ACIDS, SCOTTSDALE, AZ, 26 - 28 October 1989, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1990BS78Z00017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Gott C; Gates T; Dermody N; Brew B; Cysique L, 2016, 'Cognitive Change Trajectories in Virally Suppressed HIV-Infected Individuals Suggest High Prevalence of Ongoing Disease Activity', in JOURNAL OF NEUROVIROLOGY, SPRINGER, Toronto, CANADA, Vol. 22, pp. S24 - S25, presented at 14th International Symposium on NeuroVirology, Toronto, CANADA, 25 - 28 October 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394093700051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a